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Abstract
BENJAMIN ALEXANDER HUGHES. Mechanisms of Subtype-Specific Inhibition
of N-methyl-D-aspartate Receptors by Ethanol. (Under the direction of JOHN J.
WOODWARD).
Alcoholism is a debilitating and costly disease with rates of prevalence
totaling nearly 6% worldwide. Treating this disease has proven expensive and in
many cases ineffective due in large part to significant gaps in our knowledge of
the molecular determinants that drive the pathogenesis of the disorder. Recently,
the N-methyl-D-aspartate (NMDA) receptor has emerged as a candidate site for
the primary inhibitory actions of ethanol on nervous system function. This
receptor is an ion channel highly expressed in the nervous system that is
activated by the excitatory neurotransmitter glutamate and has been implicated in
the induction of a number of cellular phenomena including the molecular
underpinnings of learning and memory. Understanding how ethanol affects the
function of this channel both acutely and chronically is crucial to understanding
the manifestation and progression of alcohol use disorders. By employing sitedirected mutagenesis and patch-clamp electrophysiology with recombinant cellexpression of mutant and wild type NMDA receptor subunit cDNAs, my research
has identified a number of novel interacting sites of ethanol with the NMDA
receptor complex. Additionally, this work has highlighted essential differences in
both ethanol sensitivity and gating mechanics of different NMDA receptor
v

subtypes, GluN2A- and GluN2B-containing in particular. Furthermore, by
exploiting the phenomenon of bioluminescence resonance energy transfer
(BRET) my work has also demonstrated that GluN2A- and GluN2B-containing
NMDA receptor subtypes will co-assemble into novel receptor complexes.
Further teasing the differential activity of ethanol on these NMDA receptor
subtypes could lead not only to the development of novel and effective
therapeutics for alcohol use disorders, but as well engender a better
understanding of the molecular mechanisms that underlie learning and memory.
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Chapter I. Background and Significance
I.1 Alcohol and the Human Condition
Alcohol enjoys an intimate relationship with nearly every human
population on the planet and has in many ways shaped the trajectory of our
collective development. Indeed, archaeological evidence suggests that the
emergence of agrarian societies nearly 10,000 years ago (Johnson and Earle,
2000) may have been in part motivated by the desire to produce ethanolcontaining beverages. Discovered by the molecular archaeologist Dr. Patrick
McGovern amongst a number of pottery jars in a Neolithic North China village,
the oldest example of a fermented beverage dates to nearly 9,000 years in age.
Thanks to the efforts of an intrepid group of brewers at Dogfish Head Brewing
Company (Milton, Delaware), this concoction is actually commercially available
today. More contemporary examples of alcohol-driven social paradigm shifts
abound as well, including the first demonstration by a nascent U.S. government
that it could enact and enforce its own laws; evidenced by the suppression of
violent protests in response to an unpopular whiskey tax, colloquially known as
the Whiskey Rebellion of 1791.
As a rule, though, immoderate indulgence often begets misfortune, and
alcohol use is no exception. Current estimates indicate that alcohol-related
deaths constitute nearly 6% of all fatalities worldwide, with many indicators
suggesting a rise in this trend (World Health Organization, 2014). An especially
1

prescient example of the more insidious nature of alcohol consumption occurred
on the night of September 10th, 1897, when a heavily intoxicated London taxi
driver named George Smith drove his cab into the side of a building, becoming
the first known arrestee for operating a motor vehicle while inebriated
(History.com, 2009). This infamous arrest has since faded from the public
consciousness, though it heralded an enduring pattern of behavior that has
resulted in the death or disability of hundreds of thousands of people in the
United States alone. Harsh penalties including significant jail sentences and
suspension of driving privileges have helped to curb the incidence of this
phenomenon, but the behavior nevertheless persists with recent statistics pinning
alcohol-related traffic fatalities at upwards of 10,000 annually (U.S. Department
of Transportation, 2014). Drunk driving is emblematic of the profound effect
alcohol intoxication has on an individual’s capacity to appropriately weigh risk
versus reward, and is perhaps the most potent reminder of the cost of alcohol
over-indulgence. Even if one opts not to drive intoxicated, though, excessive
alcohol consumption still elicits a number of pathological neurobiological and
peripheral adaptations that, while far less apparent than a car accident, can be
equally as debilitating for the imbiber.
In the coming sections, the body of literature probing the mechanisms of
alcohol intoxication and abuse, from the earliest hypotheses on the molecular
actions of ethanol to current models of circuit level adaptive changes that drive
alcohol seeking, will be surveyed with special emphasis placed on gaps in
2

knowledge my work has sought to fill. Implicit in this review, though, will be a
discussion of the novel molecular mechanisms of neuronal function discovered a
fortiori in the pursuit of understanding the ever-prevalent scourge of alcoholism,
revealing an existential duality often overlooked by the general public and
researchers alike; that the uglier, pathological aspects of human behavior
nevertheless offer a great deal of insight into the intrinsic nature of our nature.
I.2 Early Indications of Ethanol Action: Inhibition of Excitation
As discussed, the nature of ethanol’s relationship with humanity is
multifaceted, and indeed it is perhaps unsurprising that a functional gestalt for
ethanol action on the central nervous system has proven equally elusive. The
accumulation of motor impairment and other sedative-hypnotic behaviors
observed with increasingly higher doses of alcohol led many to initially infer that
alcohol

primarily

impaired

the

efficient

transduction

of

excitatory

neurotransmission (Wallgren and Barry, 1970). Though not necessarily a faulty
assumption, this hypothesis lacked an adequately descriptive mechanism for
ethanol-induced inhibition of excitation, leading researchers to probe the intrinsic
processes governing neuronal excitability. Among these early reports it was
observed that in the squid giant axon, 2-3% solutions of ethanol reliably inhibited
action potentials. The doses employed by these studies (in the 320-480 mM
range), however, are far above the lethal limit of mammals, casting doubt on their
physiological relevance (Armstrong & Binstock, 1964; Moore, Ulbricht, & Takata,
1964). Nevertheless, some hypothesized that alcohol could impair the efficiency
3

of cation transport across the cell membrane, the elemental basis of action
potentials, thereby blunting neuronal firing and reducing excitability. Indeed,
experiments initially seemed to confirm that alcohol appeared to inhibit the
efficiency of sodium/potassium exchange by the Na+/K+ ATPase both acutely and
chronically (Israel & Salazar, 1967; Carmichael & Israel, 1975). While an
attractive mechanism of action, this hypothesis would ultimately fall out of favor
as further experiments demonstrated an apparent cell-type specificity for the
actions of ethanol, thus excluding such a generalized feature of neurons as a
primary mode of alcohol action (Wayner, Ono, & Nolley, 1975).
Incidentally, later efforts offered experimental evidence showing increased
fluidity of plasma membranes following treatment with either anesthetics or
ethanol suggesting a possible cause of blunted excitation (Chin & Goldstein,
1977; Goldstein, Chin, & Lyon, 1982). This work was largely an extension of the
Meyer and Overton theory of anesthesia, which posits that volatile anesthetics
elicit their effects by disrupting the plasma membrane. This theory was derived
from observations showing a linear correlation between the lipid solubility of an
agent and its potency as an anesthetic. This theory, and by extension the
membrane-fluidity hypothesis of ethanol action, was called into question by
experiments demonstrating that the activity of lipid-free, non-membrane bound
soluble proteins such as luciferase exhibited the same Meyer-Overton sensitivity
to anesthetics (Franks & Lieb, 1984). These observations demonstrated that
anesthesia, and by extension alcohol intoxication, was not governed by
4

membrane dynamics alone, and further implied that proteins may harbor
significant hydrophobic pockets that could accommodate anesthetic agents of
various sizes. These findings, driven by the desire to understand the
mechanisms of drug action, ultimately revealed an essential feature of protein
structure that guides drug discovery to this day, and further underscores the
reciprocal relationship between human pathology and scientific insight.
The inability of these proposed generalized features of alcohol action to
sufficiently incorporate the diverse physiological effects of ethanol at behaviorally
relevant doses implied that specific neuronal substrates must mediate
intoxication.

Phenomenologically,

in

brain

homogenates,

ethanol

was

consistently observed to elicit strong increases in concentration of the inhibitory
neurotransmitter GABA that is primarily responsible for mediating inhibition in
mammalian neurons. Subsequent radio-ligand binding studies observed that
alcohol increased the binding of tritiated agonists to low-affinity GABA receptor
sites, lending credence to this hypothesis (Hakkinen & Kulonen, 1959; Ticku,
Burch, & Davis, 1983). While encouraging, these results could not reconcile
observations intimating a direct effect of ethanol on processes mediating
excitatory currents (Nicoll, 1972). Progress in resolving these substrates thus
stalled, as the tools available to discriminate the myriad ion currents underlying
excitatory neuronal activity remained coarse at best. With the development of
high-affinity, high-potency agonists and antagonists, though, the means to isolate
and define the receptors mediating excitatory currents became available. Initially,
5

however, work probing them as sites of alcohol action progressed slowly, as
results from emerging reports made apparent that the receptors underlying
excitatory, largely glutamatergic, neurotransmission were heterogeneous and
exhibited highly idiosyncratic behavior that differentially participated in functional
roles well beyond simple signal propagation. Indeed, the initial studies describing
these myriad receptor populations added further complexity to a model of
nervous system function that was itself nascent and incomplete.
I.3 Discrimination of Post-Synaptic Excitatory Receptor Populations
The earliest descriptions of the nervous system by Claudius Galen posited
that the brain was the seat of nervous system function, sending hollow
emanations to terminal points of action on muscle groups or elsewhere, and
seemed to agree with the anatomical prominence of these structures amongst
increasingly intelligent animals. The question of what transduced central nervous
or sensory signals via these fibrils remained unknown, and, in lieu of better
hypotheses, his assertion that they ferried spirits persisted well through the era of
Descartes. Otto Dieters, a German anatomist working in the mid-nineteenth
century,

is

credited

with

establishing

the

reticular

hypothesis

of

neurotransmission, in which he asserted the nervous system was fully connected
and uninterrupted, sending electrical signals to their targets nigh instantaneously
through reticular branches (now known as axons). Among his staunchest
supporters was Camillo Golgi, who discovered a process by which neurons could
be efficiently stained and visualized under a microscope. Incidentally, a Spanish
6

contemporary of Golgi, Santiago Ramon y Cajal, used this very process, dubbed
Golgi staining, to eventually visualize distinct gaps between neurons, refuting
Golgi’s firmly held belief in the reticular hypothesis.
The question of what purpose these gaps served, however, remained
open, though many, including John Langley, a 20th century pharmacologist,
inferred they formed some sort of chemical messaging system. Via the concerted
efforts of John Langley, Otto Loewi, and others in describing the role of
acetylcholine, an excitatory neurotransmitter, in signal transmission at the
neuromuscular junction provided the first tangible evidence that signal
transduction was likely receptor mediated. This key insight provided a framework
for understanding the essential function of the central nervous system. While
ligand/receptor dynamics are today understood to be the foundational basis of
inter-neuronal communication, conclusive evidence of this paradigm did not
emerge until 1952, when Alan Hodgkin and Andrew Huxley developed the
voltage clamp method, widely considered a quantum leap in the study of cell to
cell communication and for which they shared the Nobel Prize in 1963.
This method rests on the electronic principle of voltage, which essentially
describes the “potential” of electrons, or in this case aqueously dissolved
charged ions, to move across a resistor, specifically the cell membrane: the
actual flow of electrons across a resistor is current. At its most basic, then, the
setup consists of two electrodes, one placed extracellularly and the other
intracellularly, that can, by measuring the differential electrical charges inside and
7

outside the cell, determine the membrane’s potential difference. The intracellular
electrode then injects current to establish and maintain an experimenter-defined
voltage across the membrane. When a stimulus is applied that activates ion
channels within the membrane, for example bath-application of an ion channel's
cognate agonist, the amount of current the intracellular electrode must inject to
proportionally offset the stimulus-induced change in voltage allows the
experimenter to determine functional characteristics of these channels such as
what types of ions these channels flux and how many ions they can pass (i.e. –
current). Furthermore, this system allows experimenters to pharmacologically
define and isolate what sort of ion channels underlie specific changes in
membrane potential in an otherwise diverse cellular milieu of receptors.
Refinements to this technique by Erwin Neher and Bert Sakmann during the
1970’s and 80’s, specifically introducing the concept of establishing a giga-Ohm
seal between the recording electrode and the cell membrane, have subsequently
allowed researchers to measure changes in current or voltage at the population,
cellular, and single-channel level, and earned the pair a Nobel Prize in 1991.

8

Figure I.1: Schematic depicts a voltage-clamp electrophysiological setup. The amount of
current required to offset the voltage potential difference between the reference electrode (a)
and the recording electrode (b) by the amplifier (c) in response to a stimulus, in this case
agonist application, is read by the experimenter as current conducted by the receptor
population being studied (d).

The electrophysiological techniques described above gave researchers
the tight experimental control and fine temporal precision necessary to
understand the elemental features of neurotransmission, and were essential to
early reports that established both the ionic basis of neuron excitability and the
receptor/channel-dependency of neural responses outlined by Langley, Loewi,
and others. As it was largely unknown what types of receptors governed interneuronal signaling, much less their number and functional properties, the
elucidation of these represented fertile ground for the application of this nascent
experimental

design.

electrophysiological

In

tandem

procedures,

with

the

continuing

development

of

refinements
potent,

to

selective

pharmacological agents proved invaluable in first discriminating the substrates of
these neurotransmitters and their respective roles in neural activity. Among these
early electrophysiological experiments were descriptions of amino acids evoking
both neuronal excitation (L-glutamate) and inhibition (GABA) that seemed to
reveal a binary mode of neuronal activity (Curtis & Watkins, 1960; Curtis &
Watkins, 1963). By showing that differential activity of excitatory or inhibitory
inputs on specific motor neurons in the squid could elicit either simple reflexes or
complex motivated responses, Kupfermann and Kandel (1969) showed that this
binary model of neurotransmission permitted the large scale computational
9

processing necessary to produce behavior. Additionally, the discovery of the muopioid receptor, and later additional peptidergic neurotransmitters such as
endorphin and substance P, further amended this model by incorporating the
concept of neuromodulation, in which certain classes of neurotransmitters do not
themselves directly elicit neuronal activity but instead tune the degree of
excitation or inhibition, thereby vastly increasing the computing power of
neuronal communication (Pert & Snyder, 1973; Knoishi & Otsuka, 1974). Owing
to the initial reports of robust glutamate-induced neuronal excitation, though, a
considerable premium was placed on the characterization of potent and selective
analogues of glutamate, and thus was it demonstrated that multiple receptor
subtypes with diverse signaling properties likely mediate excitatory responses
elicited by glutamate, weaving further nuance into the existing models of
neurotransmission (Johnston, Curtis, Davies, & McCulloch, 1974; Biscoe et al.,
1975).
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Figure I.2: Summation of differential excitatory and
inhibitory impulses on a postsynaptic neuron dictates
whether the neuron will fire an action potential.
Excitatory synapses exhibit a distinctive presynaptic
bouton/postsynaptic spine morphology, while inhibitory
terminals impinge directly on the dendritic shaft or cell
body (a). Blown up view of an archetypal excitatory
synapse demonstrates how influx of calcium subsequent
to arrival of an action potential at the axon terminal
bouton triggers neurotransmitter release into the
synapse, activating postsynaptic receptors that permit
entry of charged ions, ultimately further propagating the
signal down the postsynaptic neuron (b).

Interestingly enough, initial development of these glutamatergic analogues
partly arose from the search for novel anti-parasitics and insecticides that were
subsequently observed to elicit robust effects on neuronal excitation, echoing the
guiding theme that pathological states drive our understanding of basic cellular
function (Shinozaki & Konishi, 1970). Kainic acid was among these first
analogues described and produced significant excitation with application, albeit
to a much more modest degree than L-glutamate (Johnston, Curtis, Davies, &
McCulloch, 1974). Structurally similar to kainic acid, quisqualate was similarly
shown to elicit excitation, though considerably stronger than kainate and nearly
two orders of magnitude more potent than L-glutamate (Shinozaki & Shibuya,
11

1974; Biscoe et al., 1975). When rank-ordered by potency, these analogues
appeared to demonstrate two distinct receptor populations; these quisqualateand kainate-sensitive receptors are now referred to as AMPA and Kainate
respectively.
While kainate and quisqualate were shown to reliably evoke excitation,
additional contemporaneous reports showed that structurally distinct aspartate
analogues also elicited excitatory responses, albeit with slower kinetics, implying
that a class of glutamatergic receptor existed apart from AMPA and Kainate
receptors (Johnston, Curtis, Davies, & McCulloch, 1974; Biscoe et al., 1976).
Discovery of the robust antagonistic properties of DAA, and later DL-AP5 with
much higher potency, on these kainate-/quisqualate-insensitive currents finally
resolved this orphan receptor, and it was subsequently named the N-methyl-Daspartate receptor after its most potent aspartate-derived agonist (McLennan &
Hall, 1978; Collingridge & Davies, 1979; Davies & Watkins, 1979; Evans et al.,
1979; Davies & Watkins, 1982).
I.4 Unique Characteristics of the N-methyl-D-aspartate Receptor
Experiments immediately revealed that this novel receptor population
exhibited a host of unique features distinct from AMPA- and kainate-sensitive
receptor types. Chief among the first reports describing NMDA-sensitive
receptors was a consistently noted innate sensitivity to magnesium not seen with
kainate- and AMPA-type receptors as well as voltage-dependent regenerative
currents similar to sodium channels in the axon that produce action potentials
12

(Ault et al., 1980; MacDonald, Porietis, & Wojtowicz, 1982). These observations
have since been revealed to be governed by the same mechanism. Under
normal hyperpolarized neuronally quiescent conditions extracellular magnesium
infiltrates and blocks the central pore of the NMDA receptor. Upon increasing
depolarization from AMPA/Kainate receptor activity, magnesium block of
NMDARs is proportionally diminished, and with sufficient depolarization allows
ion flux through the channel. Thus, the voltage sensitivity of the NMDA-receptor
is a consequence of voltage-dependent magnesium blockade and not due to a
receptor-intrinsic physical voltage gate in contrast to axonal sodium channels
(Nowak et al., 1984; Mayer, Westbrook, & Guthrie, 1984). Depolarization-induced
relief of NMDAR magnesium blockade is consistent with initial studies showing
that NMDA application resulted in a slow accumulation of excitation (Johnston et
al., 1974), though the significance of this feature would not be fully appreciated
until later reports demonstrated that NMDA receptors are essential elements in
the molecular mechanisms of learning and memory (discussed in greater detail in
Section I.8).
While the innate Mg2+ sensitivity of the NMDAR was described, at least
phenomenologically, soon after the discovery of the receptor itself, the underlying
mechanism(s) that governed this feature remained unknown. Fortuitously,
emerging reports on AMPA receptor function would guide researchers to an
answer. Experiments conducted by the Seeburg laboratory in 1991 showed that
some AMPA receptor subunits, most prominently GluA2, underwent RNA editing
13

that resulted in substitution of the coded glutamine (Q) codon at a critical
channel-forming segment into a charged arginine (R) in certain AMPA subunits,
resulting in a number of profound changes in channel activity (Sommer et al.,
1991). Among these functional changes observed with mutation of GluA2 Q607
to an arginine was a significant attenuation of the calcium permeability of the
receptor (Puchalski et al., 1994). The constitutive prominence of GluA2containing AMPARs in the synapse under basal neurotransmission has
subsequently been suggested to be a neuroprotective adaptation to guard
against calcium-induced excitotoxicity. Specific inclusion of GluA2-lacking
AMPARs after induction of LTP (discussed later in Section I.8) may represent a
positive feedback loop to maintain calcium-dependent functional adaptations
(Kim et al., 2001).
The presence of a similarly re-entrant pore-defining region in the NMDA
receptor, coupled with reports of the high intrinsic calcium permeability of
NMDARs, prompted researchers to speculate a central role for this region in
governing ion selectivity. While the native cognate residue in NMDARs (N616) is
an asparagine instead of the glutamine or arginine present in AMPARs, reports
nevertheless observed bidirectional changes in the calcium selectivity of the
mutant receptor contingent on N/Q or N/R mutation (Burnashev et al., 1992;
Sakurada, Masu, & Nakanishi, 1993). Unexpectedly, though, these experiments
also demonstrated significant attenuation of the magnesium sensitivity of the
receptor with manipulation of this site. Ultimately, Retchless, Gao & Johnston
14

(2012) have shown that, while the sites
probed by Burnashev et al. (1992) and
Sakurada et al. (1993) participated in
defining Mg2+ sensitivity, a single residue
within the M3 domain of the GluN2
subunit (S632 in GluN2A) coordinates
with residues (largely W608) in the M2
loop of GluN1 to primarily define the
Figure I.3: General schematic depicting the
broad topology of GluN subunits. As
discussed, NMDARs are composed of 4
such subunits, two glycine-binding GluN1
and two glutamate-binding GluN2, in a
complex. The S1 and S2 domains
coordinate to define the extracellular ligand
binding site, and the membrane-spanning
domains, including the M2 reentrant loop,
are depicted in red.

interacting site for Mg2+ action (for a
schematic

of

basic

GluN

subunit

topology see Figure 3). Additionally,
comparison

of

residue

homology

between the four flavors of GluN2

subunits (A-D) revealed that innately different substitutions at the respective
homologous GluN2 M3 residues correlated significantly with both the intrinsically
lower Mg2+ sensitivities observed with GluN2C/D-containing receptors versus
their A/B counterparts as well as their intrinsically different relative Ca2+
permeabilities.
Parsing the different glutamate-sensitive ion channels via pharmacological
agents led many to wonder at the contributions of each receptor type in synaptic
signaling. By recording currents in the presence and absence of the high potency
NMDAR antagonist AP5, Jahr & Stevens (1987) dichotomized the receptor
15

populations based on response times to glutamate activation into a “fast”
component group comprised of AMPA and Kainate receptors, and a “slow”
component group consisting largely of NMDARs. Importantly, this AP5-sensitive,
slow component population appeared to exclusively govern the induction of
synaptic potentiation after high frequency stimulation, leading others to speculate
that activation of NMDARs was the mechanism underlying the most common
forms of synaptic potentiation. The aforementioned study by Jahr & Stevens
(1987) showed a high apparent calcium permeability of NMDARs, and results
from subsequent studies showed that indeed NMDARs exhibit an exceptional
selectivity for Ca2+ flux that by some estimates mediates upwards of 50% of total
charge transfer during excitation (Murphy, Thayer, & Miller, 1987; Forsythe &
Westbrook, 1988). The significance of this feature is discussed in further detail in
Section I.8, though in short it was observed in later studies that this high Ca2+
permeability acted as a link in an elegant signaling cascade between NMDARmediated activity and induction of activity of calcium-sensitive secondary effector
proteins that drive synaptic strengthening. Interestingly, the studies discussed
above demonstrating the dependency of Mg2+ sensitivity on individual residues in
the reentrant M2 loop simultaneously revealed that these residues also govern
the intrinsically high Ca2+ permeability of the NMDA receptor.
The interaction of multiple amino acids and domains in establishing basic
functional parameters of ion channels has become a guiding theme in
pharmacological research, and the studies outlined above provided the
16

foundation of comparative analysis in understanding the behavior of different
receptor types. Indeed, until recently the AMPA receptor crystal structure served
as the basis for hypothesized structures of the NMDA receptor (Sobolevsky,
Rooney, & Wollmuth, 2002). Recently, however, the structure of the GluN2Bcontaining NMDAR was solved simultaneously by two independent groups
(Karakas and Furukawa, 2014; Lee et al., 2014). Such homology comparisons
have proven essential to our understanding of ethanol action, and their
implementation along with single channel electrophysiological recordings have
enabled researchers to parse the discrete domains and gating steps that elicit
channel activation (discussed more thoroughly in Section II.1).
I.5 NMDARs Revealed to be Primary Sites of Ethanol Action
By this time, the broad strokes of innate NMDAR function and its role in
synaptic transmission were rudimentally understood, but the question of how
ethanol inhibited excitation remained open. As previously discussed in Section
I.2, ethanol was shown, in addition to potentiating GABA-mediated inhibition, to
directly affect excitatory post-synaptic activity (Nicoll, 1972). With the
discrimination

of

three

distinct

excitatory,

glutamate-sensitive

receptor

populations, divining substrate-specific actions of ethanol on neuronal excitation
became possible. Seminal work by Lovinger, White, and Weight (1989)
demonstrated that pharmacologically isolated NMDA currents were significantly
inhibited by ethanol at concentrations associated with behavioral intoxication,
while AMPA and Kainate receptor populations exhibited modest, if any,
17

attenuation at these concentrations. Given the emerging role of NMDARs in
synaptic signaling, strengthening, and cognition, these results simultaneously
aligned with behavioral manifestations of intoxication including depressed
cognitive function and, with higher levels of intoxication, impairment of memory
formation, as well as further intimated the elemental role of NMDARs in learning
and memory.
I.6 Mechanisms of Direct Inhibition of NMDAR Function by Ethanol
While Lovinger, White, and Weight (1989) showed that the NMDA
receptor constitutes a primary site of ethanol action, it nevertheless remained
unclear precisely how ethanol blunts NMDAR-mediated current. Early reports
hinted that ethanol may interfere with glycine binding to the GluN1 subunit, and
indeed such findings proved contentious from the start. Initially, experiments
appeared to show that ethanol inhibition of NMDAR-mediated calcium influx in
cerebellar granule cells and NMDA-stimulated dopamine release in striatal slices
could be blunted by the addition of increasing concentrations of glycine (Rabe &
Tabakoff, 1990; Woodward & Gonzales, 1990). Later experiments examining
NMDA currents in hippocampal neurons showed no ethanol-induced shift in the
glycine EC50 as would be expected with a competitive antagonist (Peoples &
Weight, 1992). The matter would not seem definitively settled, however, until
work by Mirshahi and Woodward (1995) demonstrated no shift in glycine EC50
with ethanol application in recombinantly expressed GluN2A- and GluN2Ccontaining NMDARs. The disparity of results between these studies was likely
18

due to differing glycine sensitivities of fully complemented receptors in intact
tissue: indeed, studies have shown that glycine sensitivity of the GluN1 subunit is
affected by what concomitant GluN2 subunit is expressed, such that otherwise
comparatively ethanol-resistant receptor populations could be recruited with
increasing glycine concentrations in native tissue (Peoples & Weight, 1992;
Ronald, Mirshahi, & Woodward, 2001; Chen et al., 2008). Consistent among all
studies, though, was the observation that ethanol did not directly compete with
glutamate or NMDA binding, nor did ethanol affect the magnesium sensitivity of
the channel (Chu, Anantharam, & Treistman, 1995; Bhave et al., 1996). Thus, it
was determined that ethanol inhibits NMDAR function via non-competitive,
voltage-independent mechanisms that are distinct from any actions as a pore
blocker.
Subsequent single-channel experiments by Wright, Peoples and Weight
(1996) ultimately showed that ethanol inhibited NMDA receptor activity by
reducing mean channel open time and channel open probability, consistent with
its role as an allosteric modulator of channel gating. Further work with NMDARs
found that, while truncation of C-termini of GluN1 or GluN2 could modify the
ethanol sensitivity of the NMDA receptor, it was primarily extracellular, not
intracellular, application of ethanol that resulted in NMDAR inhibition, suggesting
that, while the C-termini could modulate the ethanol sensitivity of the channel,
these effects were likely subsequent to ethanol interactions with core gating
elements (Peoples & Stewart, 2000). Indeed, mutagenesis studies of the GABAA
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receptor revealed that when specific residues within the transmembrane 2 (TM2)
or transmembrane 3 (TM3) domains were mutated the alcohol-induced
potentiation in current was significantly attenuated (Mihic et al., 1997). Based on
this data, Ronald, Mirshahi and Woodward (2001) hypothesized that ethanol
similarly acts as a modulator of NMDAR function by interactions with
transmembrane elements. A homology scan of the TM domains in GluN1 and
GluN2A-D subunits revealed a single residue in particular, F639 of GluN1 and
the homologous sites in the modestly differentiated GluN2 subunits, of the TM3
domain was highly conserved among NMDA subunits. Mutation of this residue in
GluN1 elicited robust reductions in ethanol sensitivity that occurred regardless of
what GluN2 subunit is expressed. Interestingly, attenuation of ethanol sensitivity
appeared positively correlated with the volume of the substituent (i.e. - the most
robust reductions in ethanol sensitivity were observed with smaller amino acids)
(Smothers & Woodward, 2006). Recent studies, though, seem to both challenge
and confirm this observation, as substitution of GluN1 F639 with a large
tryptophan elicited attenuations in ethanol sensitivity comparable to GluN1
(F639A) (Ren et al., 2012), while another study showed that GluN1 (F639C)
restored wild type ethanol sensitivity following treatment with MTS reagents that
covalently bind to cysteine residues, increasing their volume occupancy (Xu,
Smothers, & Woodward, 2015). The discrepancy between these results remains
an open question and will require further study. Functionally, substituent size also
correlated positively (ie - smaller substituents displayed higher glycine sensitivity)
with increases in glycine EC50, and suggests that amino acid/ethanol co20

occupancy within this molecular space partially governs reductions in channel
activity (Smothers & Woodward, 2006). Importantly, this residue does not face
the pore, both confirming prior data ruling out any actions of ethanol as a pore
blocker while also intimating possible interactions with residues in other gating
elements including TM4 (Mirshahi & Woodward, 1995).
In Ronald, Mirshahi and Woodward (2001) the authors were unable to
generate functional receptors in X. laevis oocytes expressing GluN1/GluN2A
(F637A) mutants, however subsequent work by Ren et al. (2007) using human
embryonic kidney (HEK) cells did obtain functional receptors and found that
manipulation of the GluN2A (F637) site resulted in profound effects on intrinsic
receptor function distinct from those observed with GluN1 (F639A)/GluN2A
receptors. Perhaps most importantly though, changes in ethanol potency seen
with GluN1/GluN2A (F637X) were negatively correlated with the volume of the
substituent amino acid (i.e. - increasing substituent size increasingly blunted
ethanol sensitivity), in contrast to GluN1 (F639X)/GluN2A mutants in which a
robust positive correlation was observed. Furthermore, with GluN1/GluN2A
(F637X) receptors, the volume occupied did not significantly correlate with
changes in mean open time of the channel, suggesting that this site in GluN2
could instead act as a barrier to ethanol infiltration of adjacent sites (Ren et al.,
2007). Indeed, substituent-specific effects on basic channel properties would be
expected if ethanol interacted directly with this site. The disparity between these
subunit-specific results and the highly homologous TM3 sequences between
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GluN1 and GluN2 was initially attributed to a hypothesized structural shift of
about 4 amino acids between the subunits (Sobolevsky, Rooney, & Wollmuth,
2002).

However,

results

from

recent

crystallographic

studies

of

the

GluN1/GluN2B structure show that this is not the case (Sobolevsky, Rooney, &
Wollmuth, 2002; Karakas & Furukawa, 2015; Science; Lee et al., 2014). In
addition, a recent study recapitulated the aforementioned experiments with
GluN2B-containing receptors and obtained results similar to those seen with
GluN2A-containing NMDARs were observed with GluN1/GluN2B (F637X) (Zhao
et al., 2015).

Figure I.4: Overhead view
of
the
transmembrane
domains that define the
central
ion-gating
pore.
Positions of GluN1 F639
residues are shown relative
to A825 residues in the M4
domain of GluN2A. Note the
size disparity between the
two residues, as well as the
seeming orientation of A825
toward the lipid interface
instead of a more direct
interaction with F639.

This disparity between GluN1 and GluN2 TM3 mutations with regard to
their effects on ethanol inhibition may reflect an intrinsic asymmetrical
contribution of the subunits and their respective gating domains to receptor
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function, consistent with emerging reports (Kazi et al., 2013). Indeed, work by Xu
et al. (2012) has further shown that when GluN2A- and GluN2B-containing
NMDARs are rendered constitutively open, they display GluN2-subtype specific
changes in ethanol sensitivity. Specifically, it was observed that GluN2Acontaining receptors showed comparable decreases in ethanol sensitivity
subsequent to either the GluN1 or GluN2 subunit being rendered open, with the
larger effect observed with GluN2A. GluN2B-containing NMDARs on the other
hand showed a robust decrease in ethanol sensitivity with GluN2 manipulation
well above that observed with manipulation of GluN1, implying a higher
proportional contribution of the GluN2B subunit to ethanol sensitivity in this
receptor type. These data pose an interesting question; namely, whether the
inherent difference in ethanol sensitivity observed between GluN2A- and
GluN2B-containing NMDA receptor types is a product of intrinsically different
gating mechanisms. This observation forms an essential part of the underlying
hypothesis for the experiments discussed in Section II.
The central location of the F639 residue and the incomplete elimination of
ethanol sensitivity of NMDARs following mutation at this site suggest that other
sites may participate in channel inhibition. Further experiments discovered a
residue, M823, in the TM4 domain of GluN2A that when mutated resulted in
significantly attenuated ethanol sensitivity (Ren, Honse, & Peoples, 2003). The
most robust attenuation of ethanol sensitivity was observed with mutation of
M823 to a tryptophan (W), while the decrease in ethanol sensitivity observed with
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other amino acid substitutions generally correlated negatively with spatial volume
of the amino acid used. Importantly, though, manipulation of this site resulted in
profound effects on basic channel properties including enhanced receptor
desensitization, complicating an interpretation for M823 as a direct interacting
site for ethanol. Thus, other residues proximal to the highly conserved M823
were evaluated for effects on ethanol inhibition, ultimately resulting in
identification of other candidate targets of ethanol action by Honse et al. (2004).
The essential finding of this report was that manipulation of residue A825 in the
TM4 of GluN2A resulted in a reduction in ethanol sensitivity over and above that
observed with similar manipulations of not only M823, but as well residues distal
and proximal to A825. Furthermore, manipulation of A825 resulted in few
changes in intrinsic receptor function, in contrast to M823. Later experiments
showed that the analogous residue in GluN2B, G826, could elicit similar
reductions in ethanol sensitivity of the channel. Importantly, though, both alanine
and especially glycine residues lack appreciable side-chains for direct ethanol
interactions, and in the case of glycine, may be required to impart essential
tertiary structure to the helix, thus limiting interpretation of this data as evidence
for a true site of ethanol action (Smothers & Woodward, abstract presented at the
Annual Meeting of the Society for Neuroscience, 2005; Zhao et al., 2015).
Caveats aside, the lack of intrinsic alterations in receptor function with
mutation of GluN2A (A825)/GluN2B (G826) similarly distinguishes this site as a
potential gate-keeper for ethanol access into the central TM3 domains, not unlike
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the effects observed with GluN1/GluN2 (F637) mutants. When both GluN1
(F639A) and GluN2A (A825W) were co-expressed, an appreciable increase in
ethanol IC50 over and above single mutants resulted, intimating that these sites
do not specifically interact to regulate ethanol sensitivity (Ren et al., 2012).
Indeed, by definition if these residues were truly epistatic in defining an alcohol
site one would expect a non-additive effect on ethanol sensitivity subsequent to
tandem site mutation. Because of this, other pairs of residues between GluN1
TM3 and GluN2A TM4, as well as GluN1 TM4 and GluN2A TM3, were evaluated
for potential interacting pairs that coordinate and define a site of ethanol action.
The results indicated that residues adjacent to GluN1 (F639), G638 in particular,
similarly resulted in robust increases in ethanol IC50 observed by Ronald,
Mirshahi, and Woodward (2001) and that, along with F639, appeared to interact
strongly with M823 and L824 in the TM4 of GluN2A. Neither residue, however,
appeared to interact with A825 (see Figure I.4), consistent with structural models
showing the side chain of A825 is pointed away from other proximal amino acids,
and could be indicative of actions of ethanol on protein-lipid interactions
(Sobolevsky, Rooney, & Wollmuth, 2002; Karakas & Furukawa, 2014; Lee et al.,
2014). Surprisingly, though, when cognate GluN1 TM4 and GluN2A TM3 pairs
were evaluated the authors observed significant attenuations in ethanol
sensitivity with individual mutation of GluN2A TM3 residues, but no apparent shift
in ethanol IC50 subsequent to mutation of GluN1 TM4 residues. Indeed, if
interactions between the GluN1 TM4 and GluN2A TM3 domains were truly
homologous to GluN1 TM3/GluN2A TM4 interactions one would expect robust
25

shifts with single mutation of cognate GluN1 TM4 residues. Thus it appears the
fundamental interactions of GluN1 TM4 and GluN2 TM4 with other receptor
domains are likely very different, consistent with observations that GluN1 and
GluN2 do not contribute homologously to channel activation (Banke & Traynelis,
2003; Kazi et al., 2013; Cummings & Popescu, 2015). Residues L819 of GluN1
and F637 of GluN2A, though, did appear to coordinate robustly in defining the
desensitization rate of the channel, reinforcing models that implicate the
movement of TM3 directly in ion channel gating with TM4 modulating gating
indirectly via its interactions with TM3 (Jones, VanDongen, & VanDongen, 2002;
Ren, Honse, & Peoples, 2003). Thus, from these experiments it can be
concluded that ethanol interacts both directly with TM3 residues to impede
channel gating as well as disrupts the modulatory functions of TM4 in the gating
cascade, and suggests TM4 residues are more than simple barriers to ethanol
access.
The participation of a canonical modulatory domain such as TM4 in
defining ethanol sensitivity of the NMDAR suggests the possibility that similarly
modulatory regions may participate as well. Indeed, a number of extracellular
and intracellular domains within the NMDA receptor are known to impact channel
activity. Specifically, work by Gielen et al. (2009) showed that the amino terminal
domain (ATD) interacts robustly with the ligand binding domain (LBD) of the
GluN2 subunit, substantially affecting the spontaneous opening/closure of the
ligand binding cleft. Based on these observations, Smothers, Jin, and Woodward
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(2013) generated ATD-deleted GluN1 and GluN2 subunits and evaluated the
ethanol sensitivity of these truncated mutants. Interestingly, the authors observed
that deletion of the ATD of GluN2A subunit resulted in a significant increase in
ethanol sensitivity of the receptor. While this effect could be attributable to relief
of Zn2+ inhibition, this seems unlikely since prior reports by this laboratory
showed that ethanol sensitivity was unchanged in receptors containing a point
mutation that renders them zinc insensitive (Woodward & Smothers, 2003). A
likelier explanation may instead rest on observations that ATD-deletion in
GluN2A receptors results in reductions in channel open probability to similar
levels seen with GluN2B receptors (Gielen et al., 2009). Therefore, in wild type
GluN2A receptors, ethanol inhibition may be less substantial due to the
intrinsically higher open probability as compared to GluN2B-containing receptors.
ATD-deletion of GluN2A yields receptors with a lower open probability thus
permitting an increase in the efficacy of ethanol (Smothers, Jin, & Woodward,
2013).
Several studies have shown that in brain, pharmacological antagonism or
genetic elimination of GluN2B renders residual NMDAR currents ethanol
insensitive, suggesting that GluN2B-containing NMDARs constitute the primary
site of ethanol action on NMDAR currents (Roberto et al., 2004; Kash, Matthews,
& Winder, 2008; Wills et al., 2012). As GluN2B selective antagonists such as
ifenprodil exert their effects via interactions with the ATD, these results suggest
that this domain is an important site of action for ethanol. In the Smothers, Jin,
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and Woodward (2013) study, however, robust inhibition of GluN2B-containing
NMDAR current by ethanol was still observed in mutants lacking the ATD that
abolished the effects of ifenprodil. This observation raises the possibility that,
while ethanol and GluN2B-selective antagonists operate at different sites on the
receptor, their effects on channel function converge. Indeed, others have shown
that ifenprodil elicits reductions in mean open time and channel open probability
in a fashion similar to those observed with ethanol (Wright, Peoples, & Weight,
1996; Amico-Ruvio et al., 2012; Bhatt et al., 2013). Functionally, ATD-deletion of
GluN2B results in no observable change in open probability, and further supports
the conclusion that changes in open probability likely underlie the results seen
with GluN2A ATD-deletion (Gielen et al.; 2009). In sum, it appears that the amino
terminal domain, while a potent regulator of ligand-mediated channel gating, is
not a primary site of ethanol action (Smothers, Jin, & Woodward, 2013).
Nevertheless, probing the actions of the ATD on channel function has revealed
that intrinsic receptor characteristics such as open probability partially dictate the
differential ethanol sensitivities observed between GluN2 subtypes. These results
are thus also important in informing the hypothetical basis for the experiments
described in Section II.
I.7 Design-Specific Disparities in Ethanol Sensitivity Reveal Alternative
Mechanisms of Alcohol Inhibition
It is important to note that while the aforementioned studies consistently
show intramolecular actions of ethanol on NMDA receptor function, the effective
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dose ranges appear to conflict with studies of NMDAR inhibition in neurons.
Typical circulating blood levels of alcohol in an intoxicated person hover in the
0.08-0.30 g/dL range and roughly correspond to millimolar concentrations of 1733. Most studies of ethanol action on recombinant NMDA receptors typically
report ~30% inhibition of current with application of 60 mM ethanol, in stark
contrast to the >60% inhibition observed by Lovinger et al. (1989) (although this
figure has since been amended by other experiments to a more generally
accepted value of ~50%) (Chandler, Sumners, & Crews, 1993). This discrepancy
highlights a potentially important disparity between native and recombinantlyexpressed NMDARs and suggests that additional factors likely participate in
ethanol inhibition of NMDARs in vivo. Indeed, increasing evidence suggests the
activity of kinases including Fyn tyrosine kinase potentiate NMDAR-mediated
currents in neuronal tissue and blunt the ethanol sensitivity of this population.
Further reports have modified this schema to include the activity of an NMDAinteracting phosphatase, Striatal-enriched Tyrosine Phosphatase (STEP), that
when knocked out in vivo appears to abolish ethanol sensitivity of NMDARmediated current (Hicklin et al., 2011). As discussed more thoroughly in Section
I.9, the action of these two secondary effectors on NMDAR-mediated currents
appear to involve regulation of surface expression rather than direct actions on
intrinsic receptor function. Nevertheless, while diametrically opposed, their
mechanisms of action were both elucidated by experimental methods that
critically hinged on both native and recombinant expression systems.
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While the interplay of these mechanisms is discussed in greater detail
later, it is prudent to further detail how the profound behavioral impairments
observed with circulating levels of ethanol may differ from the relatively low level
of NMDAR antagonism. This relationship between low efficacy and resulting high
phenotypic response to NMDAR antagonism is not simply an idiosyncratic
property of ethanol, as low doses of AP5 and resultant NMDA inhibition have
similarly been shown to abolish NMDA-dependent up states in neuronal firing (Tu
et al., 2007). This discrepancy implies not only a substantial role for NMDARs in
cellular processes beyond simple signal propagation, but as well that in addition
to direct actions on channel function these NMDA-dependent cascades may
themselves be intrinsically sensitive to alcohol.
At the most basic level, the ability of drugs like ethanol to elicit substantial
behavioral effects despite relatively modest inhibition of NMDARs may be related
to the low levels of NMDAR expression at the synapse. Electron microscope
studies of excitatory synapses have revealed that, unlike AMPA receptors,
NMDA receptors exhibit a relatively intractable level of expression, averaging
about 50 receptors per synapse regardless of size (Racca et al., 2000). AMPA
receptors by comparison can vary widely in their expression, ranging from zero
receptors in a synapse (a so-called “silent” synapse) to over 150 in large
synapses (Nusser et al., 1998; Takumi et al., 1999). Thus the cumulative effect of
50% inhibition of NMDAR-mediated current results in the silencing of half the
NMDA receptor population of nearly all excitatory synapses, and this may have
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profound implications when one considers the paramount importance of NMDA
receptor signaling in processes including cortical up-states, learning, and
memory. In the next section, then, I will provide a brief primer on the role of
NMDA receptors in the machinery that governs synaptic plasticity, the molecular
basis of learning and memory, and attempt to reconcile the disparate levels of
alcohol inhibition on NMDA receptor signaling observed between reductionist,
recombinant experiments and those conducted in neuronal tissue.
I.8 NMDARs are Essential Regulators of Synaptic Plasticity
Excitatory glutamatergic synapses are morphologically defined by a
feature called the post synaptic density (PSD) in which a host of scaffolding
proteins assemble to form an extended matrix that incorporates a number of
receptors and secondary effector proteins. Electron micrographs first revealed
this structure as a large electron dense array embedded in spines along dendritic
branches, and subsequent experiments established that PSD-containing
synapses appear to be exclusively glutamatergic (Westrum & Blackstad, 1962;
Allison et al., 1998). While successive reports continue to elucidate the finer
points of PSD function, the central role of the PSD is to act as a molecular hub
for the efficient transduction of trans-synaptic signaling between ion channels
and secondary effector proteins that regulate receptor expression as well as
basic cellular function (for review see Kennedy, 2000). Structurally, the PSD is a
conglomerate of scaffolding proteins largely composed of membrane-associated
guanylate kinases (MAGUKs) that are suspended within an actin cytoskeleton.
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An essential feature of MAGUKs are the presence of multiple PDZ domains that
allow the formation of peptide bonds with a number of different proteins
simultaneously, ultimately permitting the assembly and organization of large,
diverse signaling complexes at the cell membrane (Doyle et al., 1996; Hsueh,
Kim, & Sheng, 1997). In tandem with cycling of the actin cytoskeleton between
filamentous and globular forms, the integration and disintegration of MAGUKprotein interactions represent the most basic form of excitatory synaptic plasticity
(Allison et al., 1998).
Interestingly, among the first MAGUK-interacting proteins discovered was
the NMDA receptor, and indeed a large majority of neuronal NMDA receptors are
found within this molecular milieu (Kornau et al., 1995; Niethammer, Kim, &
Sheng, 1996). Many subtypes of NMDARs, though most notably GluN2A- and
GluN2B-containing receptors, have extensive C-termini with myriad different
consensus sequences that recognize not only PDZ domains but as well a host of
different kinases and phosphatases (Kornau et al., 1995; Niethammer, Kim, &
Sheng, 1996; Zhou et al., 2007; for review see Salter and Kalia, 2004). As
previously discussed in Section I.4, NMDA receptors display unique channel
characteristics including voltage dependence and a high calcium permeability
relative to other glutamatergic ion channels. These properties in conjunction with
an apparent affinity for C-terminal protein-protein interactions led many to
hypothesize that the NMDA receptor itself may function as a fundamental link

32

between membrane depolarization and induction of cytoskeletal rearrangements
associated with activity-dependent phenomena including long term potentiation.
Donald Hebb first postulated that learning was the aggregate result of
distributed synaptic strengthenings, specifically positing that repeated presynaptic stimulations at a synapse would elicit enhanced post-synaptic
responses over time. Owing to its veracity, this model has since been termed
“Hebbian plasticity” (Hebb, 1949). It would not be until 1973, however, that this
phenomenon would be experimentally described when Bliss and Lomo (1973)
observed heightened synaptic responses in the dentate gyrus subsequent to high
frequency stimulation of the perforant pathway stimulation. While the particulars
of that phenomena, which they dubbed “long term potentiation” (hereafter
referred to as LTP), vary, it is generally understood to constitute enhanced
synaptic transmission after induction that persists for >30min and is often, though
not always, post-synaptic and NMDA-dependent (for review see Nicoll & Roche,
2013). For the purposes of this discussion only NMDA-dependent LTP will be
addressed.
The observation of synaptic LTP posed two important questions: namely,
(1) what type(s) of receptors mediate this phenomenon, and (2) by what
mechanism do these receptors induce synaptic potentiation? Using a variety of
pharmacological agents Collingridge, Kehl, and McLennan (1983) demonstrated
that kainate and AMPA receptors largely mediate fast excitatory synaptic
transmission while NMDARs seem to contribute only modestly. Importantly and
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somewhat counter-intuitively, the authors observed that application of an
NMDAR-selective antagonist, DL-AP5, blocked the induction of synaptic
potentiation, heavily implying a central role for the NMDA receptor in governing
LTP. Additional experiments further showed that, while NMDARs are essential
for the induction of LTP, AMPA-mediated currents appear to underlie the actual
expression and maintenance of enhanced synaptic signaling, suggesting
NMDARs are themselves not significantly potentiated (Muller, Joly, & Lynch,
1988; Davies et al., 1989).
As discussed previously, a number of idiosyncratic features make the
NMDA receptor uniquely suited to fulfill a role as a central hub for coordinating
synaptic signaling with the mechanics of synaptic strengthening. Among these
features is the inherent voltage-dependent blockade of NMDARs by magnesium,
whose relevance to long term potentiation became apparent subsequent to work
published by Herron et al. (1986). In this study, the authors showed that induction
of LTP was frequency-specific, requiring high levels of stimulation to relieve this
magnesium block and allow ion flow through NMDARs. Thus, in concert with the
NMDA receptor’s intrinsically high calcium permeability, voltage-dependent
magnesium blockade permits the NMDA receptor to act as a coincidence
detector

linking

post-synaptic

depolarization,

via

synaptic

activation

of

AMPA/Kainate receptors, back-propagating depolarization from firing of an action
potential, or both, with calcium-sensitive cellular mechanisms of synaptic
potentiation.
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Importantly, initial studies of LTP showed that expression of the
phenomenon was not only sensitive to extracellular concentrations of Mg 2+,
consistent with a central role for NMDARs in eliciting LTP, but to levels of free
calcium as well (Dunwiddie & Lynch, 1979). Further experiments by this group
revealed that high frequency stimulation of hippocampal tissue in low-calcium
extracellular solution did not exhibit enhanced binding of tritiated glutamate
observed with normal calcium levels, indicating calcium may be essential to postsynaptic mechanisms of potentiation (Lynch, Halpain, & Baudry, 1982). By
intracellularly injecting EGTA, a calcium chelator, into the post-synaptic neuron,
Lynch et al. (1983) determined that LTP is indeed a post-synaptic phenomenon,
dependent on influx of extracellular Ca2+ into the post-synaptic neuron, later
shown to occur specifically via influx through NMDA receptors (Frank et al.,
1989).
Though at this point it was understood that the long-term cellular
processes induced by NMDA activity relied significantly on calcium flux through
NMDARs, the ultimate consequence of this calcium influx was not known. Davies
et al. (1989) observed slow increases in the sensitivity of neurons to
iontophoretically-applied AMPA receptor agonists after induction of LTP
suggesting AMPARs mediate the expression of LTP. It remained unclear,
however, if this was due to a functional change in the unitary conductance of the
AMPA receptor or to increased AMPAR expression. More fundamentally, though,
a link between NMDAR-mediated Ca2+ influx and this AMPA-mediated current
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facilitation was lacking. Owing to the vast expression of Ca2+/calmodulindependent protein kinase II (CaMKII) in the forebrain, by some estimates
comprising nearly 2% of the total protein, CaMKII began to emerge as a possible
intermediary in this cascade (Erondu & Kennedy, 1985). Experiments conducted
by Malinow, Madison, and Tsien (1988) were among the first to pose and test the
hypothesis that induction of protein kinase activity could link Ca2+ influx through
NMDARs to enhancement of AMPA-mediated currents. Using intracellular
injection of calmidazolium, a calmodulin antagonist, it was further shown that
activation of CaMKII, a dodecameric kinase activated by calcium-bound
calmodulin, is required for eliciting post-synaptic potentiation (Malenka et al.,
1989). Importantly, experiments showed that the role of NMDA receptors in
CaMKII activity was two-fold: namely, Ca2+ influx through NMDARs activated
calmodulin binding to CaMKII, and the extensive C-terminal tails of GluN2
subunits (GluN2B in particular) act as molecular scaffolds for CaMKII to
autophosphorylate its own regulatory domains thus further enhancing activity
(Strack & Colbran, 1998; Leonard et al., 2002; Bayer et al., 2001).
While the observed effects of CaMKII antagonists on LTP suggested a
necessary role for the protein, the final link between CaMKII activity and
upregulation of AMPA current remained an open question. A tentative answer
emerged when experiments by Tan, Wenthold, and Soderling (1994) showed
that treatment of cultured hippocampal neurons with stimulators of CaMKII and
PKA kinases resulted in a significant increase in AMPA receptor phosphorylation
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that was blocked by pretreatment with the NMDA receptor antagonist AP5, or
KN-62, a CaMKII inhibitor. Later studies ultimately showed that AMPA subunits,
GluA1 in particular, displayed CaMKII consensus sequences that exhibited a
strong positive correlation between their phosphorylation state and the
magnitude of AMPA current potentiation (Barria et al., 1997; Mammen et al.,
1997; Barria, Derkach, & Soderling, 1997). While contemporaneous evidence
suggested that phosphorylation of AMPAR subunits was itself sufficient to
increase AMPA-mediated current (Raymond, Blackstone, & Huganir, 1993),
other mechanisms likely mediated upregulated AMPA current after LTP
induction. Indeed, experiments performed by Ehlers (2000) demonstrated that
elevated levels of synaptic activity could induce reinsertion of endosomally bound
AMPARs into the plasma membrane. Further work similarly showed that
induction of LTP critically relied on AMPA receptor insertion into the plasma
membrane, definitively demonstrating that LTP-induced upregulation of AMPA
current was the product of receptor phosphorylation that then signaled
membrane targeting (Lu et al., 2001). Refinements to this model continued to
emerge, ultimately revealing that differential subunit phosphorylation drove not
only GluA1-containing AMPAR insertion into the membrane, but as well
simultaneous GluA2-containing receptor internalization (Chung et al., 2000;
Esteban et al., 2003).
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Figure I.5: Many forms of plasticity are
NMDA
dependent.
Panel
(a.)
demonstrates that after high frequency
stimulation (usually 3-4 1 sec bursts of
100 Hz stimulation) current amplitudes
of the recorded neuron increase
substantially, and remain elevated for
hours after LTP induction. When an
NMDA antagonist (AP5) is present
during stimulation, though, LTP is not
induced. Panel (b.) illustrates the
molecular
mechanisms
underlying
observed increases in current amplitude
following LTP induction. 1.) High
frequency stimulation causes AMPARs
2+
to open, relieving Mg
blockade of
NMDARs and permitting subsequent
2+
2+
Ca
influx. 2.) Ca
then binds
Calmodulin, activating CaMKII (purple),
that
then
3.)
phosphorylates
endosomally-bound AMPA receptors,
4.) signaling their insertion into the
plasma membrane. The net result is
thus a “potentiated” synapse.

While the mechanism of LTP thus described represents only one of a
number of NMDA-dependent forms of plasticity, it nevertheless highlights the
multiple interactions and events that NMDA receptor activity governs that guide
and shape homeostasis. That homeostasis is itself such a dynamic process has
led many to question whether drugs of abuse impair or co-opt this innate
machinery to drive drug-seeking behavior. Indeed emerging evidence suggests
dysfunction in NMDA receptor homeostasis is, if not a primary etiology, a
secondary pathology of extended alcohol exposure that seems to promote
maladaptive seeking behaviors. The dichotomy of alcohol action between acute
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inhibition of NMDAR function and secondary disruptions of NMDA-dependent
plasticity and homeostasis is an interesting phenomenon, and indeed it remains
unclear as to whether the two events are mutually exclusive. This suggestion
forms the hypothetical basis for experiments detailed in Section III. In any case,
the alcohol-induced changes in NMDA receptor function and expression with
chronic exposure appear to be driven by mechanisms distinct from those
described that drive LTP, and constitute a form of “meta-plasticity”, in which the
regulators of plasticity themselves become the targets of modulation, and serves
to further underscore the critical importance of NMDARs in pathology of
alcoholism.
I.9 Homeostatic Changes in NMDA Receptor Expression After Extended Alcohol
Exposure
Given the pivotal role of the NMDA receptor in eliciting plasticity, inhibition
of its activity should have profound effects on normal synaptic function even with
low levels of antagonism, echoing the point made in Section I.7. Furthermore, the
previously detailed two-fold role of NMDARs in eliciting plasticity, specifically their
high innate calcium permeability and predisposition to act as a molecular
scaffold, explains the high phenotypic response to relatively modest levels of
NMDA antagonism by alcohol. In fact, as will be detailed, substantial evidence
has emerged suggesting that alcohol inhibits not only NMDAR channel gating,
but additionally alters the regulation of receptor surface expression in a highly
dynamic fashion.
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Although results from initial experiments by Peoples and Stewart (2000)
discounted a role of intracellular domains in mediating the direct actions of
alcohol on NMDA receptor function, the prevalence of studies suggesting that
secondary effector proteins known to associate with NMDARs could influence
ethanol sensitivity in neurons nevertheless accumulated. Among the first reports
describing this phenomena were observations by Miyakawa et al. (1997). In this
study, knockout of Fyn, a neuronally enriched tyrosine kinase and intimate
associate of NMDA receptors, in mice resulted in the elimination of acute
tolerance to ethanol inhibition typically seen with extended alcohol application.
This finding fostered other studies to determine what role, if any, kinases had in
governing the sensitivity of NMDARs to acute ethanol exposure.
Chief among these was a report by Anders et. al. (1999) that showed a
robust reduction in ethanol sensitivity, and concomitant increase in tyrosine
phosphorylation, of recombinantly expressed GluN2A-containing NMDARs when
co-expressed with Fyn. Oddly, though, no effect was seen with co-expression of
Fyn and GluN2B-containing NMDARs, that displayed similar increases in
tyrosine phosphorylation as GluN2A and that is known to intimately associate
with Fyn (Salter and Kalia, 2004). Later work by this laboratory ultimately
demonstrated that the effect of Fyn co-expression on GluN2A ethanol sensitivity
was due to Fyn-mediated relief of tonic Zn2+ inhibition, consistent with
observations that the phosphorylation state of C-terminal tyrosines on GluN2A
can affect Zn2+ sensitivity of the channel (Zheng et al., 1998; Woodward, 2004).
40

Nevertheless, the kinase-mediated reductions in ethanol sensitivity reported by
these authors, though statistically significant, appeared modest at best and such
receptors retained significant amounts of inhibition. Indeed, evaluation of coexpression of other kinases or mutation of C-terminal consensus sites of
phosphorylation revealed only slight or no changes in ethanol sensitivity of
recombinantly expressed NMDARs (Anders et al., 1999; Xu, Chandler, &
Woodward 2008; Xu, Smothers, & Woodward, 2011). Furthermore, single
channel studies of NMDARs have shown that phosphorylation state of C-terminal
residues appear to impact channel function, underscoring this disparity and
ultimately becoming an essential justification for the experiments detailed in
Section III (Murphy et al.; 2014 : Aman et al.; 2014).
Irrespective of these aforementioned conflicts in data, substantial
evidence simultaneously emerged that the phosphorylation state of NMDAR Cterminal residues correlated significantly with receptor surface expression. While
association of kinases and phosphatases with NMDARs

was already

documented, a report by Hall and Soderling (1997) was among the first showing
that under basal circumstances, neuronal NMDARs exhibit extensive GluN2
subunit phosphorylation. This increases following cell stimulation with glutamate
application and GluN2 phosphorylation correlates significantly with receptor
inclusion in the plasma membrane (Wang & Salter, 1994). Strangely, the authors
reported that primarily serine, not tyrosine, residues accounted for this increase
in phosphorylation, in stark contrast to earlier studies showing that GluN2
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subunits display extensive tyrosine phosphorylation after induction of LTP (Lau &
Huganir, 1995; Rostas et al., 1996). This discrepancy may have been due to the
use of dispersed cultured neurons by Hall and Soderling, as opposed to use of
intact tissue employed by others, since these cells are not fully developed and
exhibit lower levels of tyrosine kinase expression, including Fyn (Yagi et al.,
1994). Nevertheless, this spurred others to investigate the role of posttranslational modifications of GluN2 C-termini in the regulation of receptor
surface expression, culminating in the elucidation of a highly dynamic and
subunit-selective process that is inherently alcohol-sensitive.
While Miyakawa et al. (1997) demonstrated an essential association of
Fyn and GluN2B-containing NMDARs in mediating acute ethanol tolerance,
further revelations by Yaka et al. (2002) and others showed that extensive
interactions between a host of secondary effector molecules coordinated during
basal and post-stimulation conditions effectively govern the relative surface
expression of predominantly GluN2B-containing NMDARs (Roche et al., 2001;
Lavezzari et al., 2003; Prybylowski et al., 2005). This GluN2B-dependency
specifically seems to be due to the presence of the high-consensus YEKL
(tyrosine-glutamate-lysine-leucine) domain at the extreme C-terminus that
promotes binding of adapter protein 2 (AP-2) (Roche et al., 2001; Lavezzari et
al.; 2003). As its name implies, the function of this protein largely consists of
acting as an adapter between the substrate, in this case the GluN2B subunit of
NMDA receptors, and the recruitment and binding of clathrin, a protein that self
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assembles into cage-like structures forming endosomes that ultimately internalize
the AP-2-bound substrate. Importantly, the binding of AP-2 to the YEKL site on
GluN2B is intimately determined by the phosphorylation state. Specifically, AP-2
will only bind when Y1472 of this consensus site is dephosphorylated. Thus, the
Fyn-dependent acute tolerance to ethanol observed by Miyakawa et al. (1997)
could have been a product of blunted AP-2 association subsequent to
heightened phosphorylation of GluN2B, and indeed later work by Yaka et al.
(2002), Yaka, Phamluong, and Ron (2003), and Wang et al. (2007) has since
borne out this mechanism. In addition, work by these authors and others has
modified this schema to include the essential ethanol-sensitive element RACK1
that, following alcohol exposure, dissociates from the complex allowing Fyn to
phosphorylate GluN2B.
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Figure I.6: Diagram of
repeated ethanol exposure on
NMDA receptor expression.
Panel (a.) shows how Fynmediated
phosphorylation
promotes the insertion of
endosomal pools of NMDARs
into the plasma membrane.
Panel (b.), adapted from
Wang et al. (2010), shows the
cumulative effect on NMDARmediated current of ethanolinduced Fyn activity. Ethanol
treatment
enhances
Dopamine
D1
receptor
signaling (1.), inducing Fyn
activity (2.), that promotes
NMDAR insertion into the
plasma
membrane
(3.),
overcoming ethanol inhibition.

Thus, the induction of Fyn activity, potentially via enhanced Dopamine D1
receptor signaling, following ethanol administration appears to be a homeostatic
mechanism that restores NMDAR-mediated current blunted by ethanol (Wang et
al., 2010; Xu et al., 2015). This effect is observed functionally as a rebound in
NMDAR current over and above baseline levels that is apparent following alcohol
washout.

The

effector

cascade

described

above

likely

underlies

this

phenomenon specifically by heightening Y1472 phosphorylation, thereby
blocking AP-2 binding to GluN2B and ultimately both stabilizing NMDAR surface
expression and facilitating the insertion of endosomal pools of NMDA receptors
into membrane. This increase in surface-bound receptors is opposed to
functional up-regulation via enhanced unitary conductance, etc. based on the
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previously detailed work of Anders et al. (1999), Xu et al. (2008), and Xu et al.
(2011). Interestingly, repeated induction of this phenomenon in dorsal striatum by
cycles of ethanol administration appears to result in persistently heightened
NMDAR signaling well above baseline, and has been given the moniker “longterm facilitation” by Wang et al. (2007). Long-term facilitation appears essential to
the pathogenesis of maladaptive behaviors with chronic alcohol exposure, and its
expression in dorsomedial striatum appears sufficient to drive elevated alcohol
drinking behaviors (Wang et al., 2010).
While an attractive mechanism for acute tolerance observed with ethanol
exposure, the converse seemed equally plausible for governing acute inhibition
by ethanol: specifically, that ethanol-induced dephosphorylation of GluN2B,
subsequently provoking internalization of the receptor complex by AP-2, may
partially underlie ethanol inhibition and resolve the disparate observations in
ethanol sensitivity noted between recombinant and native tissue experiments.
Indeed, building on an accumulating body of evidence showing high interacting
specificity of striatal-enriched protein tyrosine phosphatase (STEP) with GluN2B,
Wu et. al. (2010) showed that not only did ethanol exposed neuronal tissue
exhibit significant dephosphorylation of GluN2B C-terminal tyrosine residues (e.g.
– Y1252, Y1336, and Y1472), but that such ethanol treatment also correlated
with increased STEP33, a soluble form of STEP, expression (Snyder et al., 2005;
Kurub et al., 2010). Further work by this group ultimately showed that in brain
slices treated with a dominant-negative form of STEP, STEP C/S, no ethanol
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inhibition was observed. Interestingly though, and consistent with the canonical
functions of Fyn suggested by Miyakawa et al. (1997) and Wang et al. (2007),
compensatory facilitation of NMDAR-mediated current was still observed
following ethanol washout.

Figure I.7: Diagram showing ethanol-induced STEP activity resulting in diminished NMDARmediated current. 1.) Ethanol initially blocks NMDAR current via direct interactions with the
receptor, but with extended application induced the activity of STEP. 2.) STEP
dephosphorylates C-terminal tyrosine residues on GluN2B, signaling the binding of AP-2
(orange) to GluN2B, ultimately recruiting clathrin (purple) resulting in endocytosis of affected
NMDAR complexes. 3.) The net result is diminished NMDAR current. After washout of
ethanol, the endosomally-bound NMDARs can be targeted either for proteolytic degradation,
or, as work by Wang et al. (2010) has shown, reinserted into the plasma membrane.

Still unclear, however, is in what manner these opposing cascades are
induced, and indeed whether or not they are in fact mutually exclusive. Emerging
reports suggest that a central factor temporally distinguishing STEP-mediated
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NMDAR down-regulation and Fyn-mediated compensatory up-regulation is
ethanol-induced facilitation of activity of the dopamine D1 receptor (Xu et al.,
2015). Specifically, induction of PKA activity by ethanol/D1 results in STEP
inhibition, resulting in PTPα dis-inhibition (a regulator of Fyn activity) that
ultimately dephosphorylates regulatory sites on Fyn permitting up-regulation of
NMDAR-mediated current. This model is consistent with previous work showing
persistent up-regulation and synaptic targeting of GluN2B-containing NMDARs
that was PKA dependent and that may represent a sensitization of the system to
ethanol-induced synaptic plasticity (Carpenter-Hyland, Woodward, & Chandler,
2004; Wang et al., 2007; Clapp et al., 2010). That this paradigm does not include
a basis for ethanol-induced STEP activity is curious and seems to argue that
STEP up-regulation is not necessarily a primary feature of alcohol inhibition of
NMDA

receptors.

Indeed,

while

others

have

shown

that

enhanced

phosphorylation of GluN2B by Fyn does not result in any appreciable increase in
unitary enhancement of receptor function, the converse experiment, whether
dephosphorylation of STEP-interacting residues on GluN2B directly affects
channel function and ethanol sensitivity, is as yet untested and represents a gap
in the literature that studies outline in Section III has sought to fill.
I.10 Differential Ethanol Sensitivity of NMDAR Subtypes: Implications for
Compensatory Plasticity
As discussed, the NMDA receptor is a critical link in a number of cellular
processes that form the basis of synaptic plasticity. Significant evidence shows
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that in addition to the acute effects of ethanol on receptor function, extended
application can result in the recruitment of adaptive mechanisms that up-regulate
receptor function and restore homeostasis. Such maladaptive changes in the
activity of these metaplastic elements are not only persistent but have been
shown to drive pathological behaviors. Though these late phase mechanisms of
NMDAR regulation display an apparent preference for GluN2B-containing
NMDARs, it is important to remember that NMDAR populations exist as a rich
milieu of subtypes at most synapses and that accumulating evidence shows
exhibit differential sensitivities to ethanol depending on GluN2 subtype. The
significance of this becomes apparent when considering work by Foster et al.
(2010) and Kim et al. (2005) demonstrating vastly different roles for GluN2A- and
GluN2B-containing NMDARs in eliciting specific types and magnitudes of
synaptic plasticity. Thus a fundamental understanding of how ethanol
preferentially inhibits these receptor subtypes could reveal the relative
contribution of these receptor types in the pathogenesis of alcoholism. This
question, in concert with the possible extraneous intramolecular sites of alcohol
action on the NMDA receptor outlined in Section I.6, thus represents the driving
hypothesis of experiments discussed in the following section.
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Chapter II. Differential Gating of GluN2A and GluN2B Receptor Types
Govern Ethanol Sensitivity
II.1 Introduction
As discussed extensively in Section I, the NMDA receptor is an essential
mediator of excitatory neurotransmission, and in addition acts as a central link
that transduces levels of excitation into long term cellular adaptations. NMDARs
are large, tetrameric complexes composed of two obligate, glycine-binding GluN1
subunits and two glutamate-binding GluN2 subunits and each display their own
unique intramolecular interacting sites, as well as vastly divergent sites of
intermolecular interaction such as their extensive intracellular C-termini. Owing to
its prominence in forebrain signaling, NMDA receptor dysfunction has been
implicated in a number of pathological states including addiction and
schizophrenia (Cull-Candy et al., 2001). In addition to their innate gross
complexity is the potential inclusion of 8 different splice variants of GluN1 as well
as four different isoforms of GluN2 subunits that themselves can vastly affect the
functional properties and intermolecular interactions of the fully complemented
receptor. It is perhaps unsurprising, then, that a precise understanding of how
ethanol inhibits these channels remains elusive. Nevertheless, work by our
laboratory and others have identified a number of key sites within the core
membrane-spanning (M) elements that, when mutated, can substantially alter the
ethanol sensitivity of the channel.
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Two sites in particular, F639 in the M3 domain of GluN1 and A825 in the
M4 domain of GluN2A, robustly diminish ethanol sensitivity when mutated to a
smaller alanine (A) residue or larger tryptophan (W) residue respectively (Ronald
et al., 2001; Ren et al., 2003; Smothers and Woodard, 2006). When the
analogous M3 residue of GluN2A, F637, was mutated, however, no apparent
change in ethanol sensitivity was observed, suggesting non-homologous roles for
GluN1 and GluN2 transmembrane elements in dictating ethanol sensitivity (Ren
et al.; 2008). Furthermore, studies by our laboratory and others have shown that
not only does NMDAR sensitivity to ethanol vary in a GluN2 subtype-dependent
fashion (e.g. between GluN2A and GluN2B subtypes), but that mutating
homologous M4 sites of alcohol activity between GluN2A and GluN2B (e.g. A825W and G825W) also elicits unequal alterations in ethanol sensitivity similarly
described above between GluN1/GluN2 M3 residues (Xu et al., 2012; Zhao et al.,
2015; Hughes and Woodward; unpublished observations).

(Hughes and Woodward; Unpublished Observations)
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Figure II.1: The left panel shows concentration-response relationships between wild type
and mutant GluN2A- and GluN2B-containing NMDA receptors expressed in HEK cells with
acute application (10 sec) of increasing concentrations of ethanol. The right panel shows
the quantification of the effects of M4 residue mutation on ethanol IC 50 values (left panel),
revealing non-homologous changes in alcohol sensitivity between GluN2A and GluN2B
receptor types.

Kinetic modeling of NMDA receptor gating developed by Popescu and
Auerbach (2004) has shown that, while the transmembrane elements are core
determinants of channel gating, other extracellular sites also govern channel
activity. Specifically, work by Kazi et al. (2013) has shown that the linker regions
between the S1/M1 and S2/M4 domains participate strongly in unequally
assigning GluN subunit participation in the gating cascade, with the GluN2
subunit in particular predominantly determining the final closed to open transition
state. Their results also revealed that conformationally restricting the movement
of these linkers by cysteine-crosslinking elicited reductions in open probability
and mean open time of the channel that strongly resembled those observed in
wild type receptors exposed to ethanol (Wright et al., 1996; Kazi et al., 2013).
Indeed, Smothers and Woodward (2006) showed that receptors containing both
the GluN1 F639A and GluN2A A825W mutations still displayed residual
sensitivity to alcohol, suggesting other sites of alcohol action.
Thus, via conformationally restricting or enhancing mobility of these linker
regions, we sought to evaluate a three-fold hypothesis: 1.) Changes in linker
domain mobility will significantly alter ethanol sensitivity, 2.) Altering linker
domain mobility will reveal fundamentally different gating profiles between
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GluN2A- and GluN2B-containing NMDA receptors, and 3.) The essential gating
differences between GluN2A- and GluN2B-containing receptors will partially
explain the intrinsic differences in ethanol sensitivity between the receptor
subtypes. Experimentally, we have chosen to exploit the phenomenon of
cysteine substitution and disulfide crosslinking described by Kazi et al. (2013) to
restrict linker mobility, in which intra-domain proximal residue pairs are mutated
to cysteines and allowed to spontaneously form disulfide bridges, restricting the
movement of that region. Increasing the mobility of the linker regions was
accomplished by substituting select intra-domain residues to a rotationally active
glycine residue.
II.2 Materials and Methods
Cell culture and mutagenesis
Human embryonic kidney (HEK) 293 cells were obtained from ATCC
(Manassas, VA) and maintained in 10 cm culture dishes containing serumsupplemented DMEM in a humidified incubator with 5% CO 2. For recordings,
cells were split and plated on poly-ornithine coated 35 mm dishes and 24 hrs
later transfected with cDNA plasmids using Lipofectamine 2000 (Invitrogen Inc,
Carlsbad, CA). Plasmids containing rat GluN1, wild-type or mutant rat GluN2A or
GluN2B, and an enhanced green fluorescent protein for cell selection were
transfected at a 3:3:1 ratio unless otherwise noted. All mutant receptor subunits
were generated using the Quik Change II site-directed mutagenesis kit (Agilent
Technologies, Santa Clara, CA) and were subsequently verified via sequencing
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(Genewiz, South Plainfield, NJ). Residues selected for cysteine substitution were
specifically derived from Kazi et al. (2013) and are as follows (residue numbering
schema used by Wollmuth laboratory indicated in parentheses): Intra-GluN1
M1:M4 = S549 (531):F810 (792), Intra-GluN2A M1:M4 = V544 (525):D815 (796),
Intra-GluN2B M1:M4 = V545 (526):D816 (797), Inter GluN1 M4:GuN2A M1 =
P805 (787):S554 (535), Inter GluN1 M4:GluN2B M1 = P805 (787):S555 (536).
These residues were previously shown in Kazi et al. (2013) to only exhibit
crosslinking when expressed in tandem, with no change in receptor function
observed in single cysteine mutants. Prior to transfection, cell media was
exchanged for fresh media containing 5 mM MgCl2 and 0.5 mM AP5 (Abcam,
Cambridge, MA) to prevent excitotoxic cell death. Experiments were conducted
24 hrs post-transfection and after extensive washing to remove NMDA
antagonists.
Electrophysiological recordings
Dishes containing transfected cells were mounted on an Olympus IX50
inverted microscope (Waltham, MA) and were perfused with an extracellular
solution at a rate of 1-2 mL/min at room temperature. Extracellular recording
solution contained the following (in mM); NaCl (135), KCl (5.4), CaCl2 (1.8),
HEPES (5), glucose (10), (pH adjusted to 7.4 with 1 M NaOH, and osmolarity
adjusted to 315-325 mOsm with sucrose). Patch pipettes (2-5 MOhms) were
pulled from standard wall borosilicate glass (1.5 x 0.85 mm) and filled with
internal solution containing the following (in mM); CsCl (140), MgCl2 (2), EGTA
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(5), HEPES (10), NaATP (2), NaGTP (0.3), (pH adjusted to 7.2 with 2 M CsOH,
and osmolarity adjusted to 290-295 mOsm with sucrose). Transfected cells were
identified by eGFP fluorescence and whole-cell voltage clamp recordings were
performed using an Axon Instruments 200B microamplifier (Molecular Devices,
Union City, CA). Cells were held at -70 mV to monitor breakthrough and
maintained at this potential unless otherwise noted. Access resistance was
monitored throughout the experiment and cells demonstrating unstable holding
currents or significant changes in series resistance were excluded from analysis.
NMDA currents were evoked using a Warner FastStep multi-barrel perfusion
system (Hamden, CT) programmed to switch between extracellular recording
solution and solution containing agonist (10 µM glutamate and glycine) or agonist
plus ethanol (30-300 mM). For cysteine crosslinking experiments, once all
concentrations of ethanol were tested, cells were treated with 10 mM DTT for 20
seconds immediately followed by three consecutive 2-sec pulses of 10 µM
Glu/Gly. These responses were used to determine percent DTT-potentiation by
comparing them to the mean of currents obtained in the same cell during the
ethanol experiments. Glutamate concentration-response curves were acquired
by increasing the concentration of glutamate from 0.1-30 µM for GluN2A
experiments, and 0.03-10 µM for GluN2B experiments. The order of solutions
was interleaved to account for any time-related effects. For MK-801 decay
experiments, 5 µM MK-801 (Sigma-Aldrich, St. Louis, MO) was applied in the
continuous presence of 10 µM glutamate/glycine for 7.5 seconds, then the cell
was returned to glutamate/glycine-only solution. All data were filtered at 1-2 kHz
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and acquired at 5 kHz using an Instrutech ITC-16 digital interface (HEKA
Instruments, Bellmore, NY) and analyzed offline by Axograph X software
(Axograph Scientific, Sydney, NSW, Australia). Ethanol was purchased from
Pharmco-Aaper (Brookfield, CT) and all other chemicals were obtained from
Sigma-Aldrich (St. Louis, MO) unless otherwise noted.
Data analysis
For glutamate concentration-response experiments, Prizm 6.0 software
(GraphPad Software, San Diego, CA) was used to calculate EC50 and Hill
coefficient via the equation y = Emax / (1 + 10^((Log{IC50 or EC50} - Log[x])* nH)),
where Emax is the maximum current evoked, nH is the Hill coefficient, y is the
measured response amplitude, and [x] is the concentration of glutamate. Curves
were fit to data obtained from individual cells with the minima and maxima
constrained to zero and 100 respectively, and derived log EC 50 values were
statistically compared using one-way analysis of variance (ANOVA) and
Dunnett's post test. All values are reported as mean ± S.E.M. Note that in Figure
6 all mutants were analyzed simultaneously with those in Figure 5F and only
divided into separate graphs for clarity. For ethanol experiments, a two-way
ANOVA with Dunnett's post test was used to statistically compare mutationdependent changes in ethanol sensitivity across doses versus wild type. In DTT
experiments, responses from individual cells were analyzed using a one-sample
t-test (control set to 100%) followed by inter-group comparison using one-way
ANOVA and Dunnett's post-hoc test. In MK-801 decay experiments, a single
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exponential function was fit to the MK-801-induced current decay for each cell
using the curve fitting routine in AxographX (Axograph Scientific, Sydney, NSW,
Australia), and the time constant of inhibition was then used to calculate the rate
of inhibition (1/τMK-801).
II.3 Results

Figure II.2: Sequence of extracellular linkers and structural topology of GluN subunits. A,
Amino acid sequence of S1-M1 and S2-M4 linker domains of GluN1 and GluN2 subunits.
B, Cartoon depicts the broad structural topology of GluN subunits, highlighting the
locations of the ligand binding domain-forming S1/S2 domains, transmembrane (TM)
domains, and the S1-M1/S2-M4 linker domains. C-D, Structural models showing the
relative locations of cysteine-substituted residues of inter- and intra-subunit crosslinked
GluN2B- (C) and GluN2A-containing (D) receptors. MacPymol (The PyMOL Molecular
Graphics System, Version 1.5.0.4 Schrödinger, LLC) was used to render structures of
GluN1/GluN2B (PDB ID: 4PE5; Karakas and Furukawa, 2014) and a homology model of
the GluN1/GluN2A receptor described in a previous study (Xu et al., 2012) that was based
on the GluA2 structure (PDB ID: 3KG2; Sobolevsky et al., 2009).
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Figure II.3: Concentration-dependent inhibition of crosslinked receptors by ethanol. A, IntraGluN1 crosslinked GluN2A receptors showed a significant reduction in ethanol sensitivity
compared to GluN1/GluN2A wild type receptors. Bar graph shows mean ± S.E.M. inhibition of
agonist-evoked currents by 30, 100, and 300 mM doses of ethanol (* p < 0.05; two-way
ANOVA with Dunnett’s test; effect of mutation, F 3,87 = 5.002; N = 6-10 cells). B,
Representative trace showing current inhibition by 300 mM ethanol of a GluN1/GluN2A wild
type NMDAR. C, Similar to results observed in GluN1/GluN2A receptors, only intra-GluN1
crosslinked GluN2B receptors showed a significant reduction in ethanol sensitivity compared
to GluN1/GluN2B wild type receptors. Bar graph shows mean ± S.E.M. inhibition of agonistevoked currents by 30, 100, and 300 mM doses of ethanol (* p < 0.05; two-way ANOVA with
Dunnett’s test; effect of mutation, F3,93 = 7.232; N = 7-10 cells). D, Representative trace
showing current inhibition by 300 mM ethanol of a GluN1/GluN2B wild type NMDAR.

Intra-subunit GluN1 S1-M1/S2-M4 linker crosslinking decreases ethanol
sensitivity of GluN2A- and GluN2B-containing NMDA receptors
Figure II.2.A shows the amino acid sequence of S1-M1 and S2-M4 linkers
of GluN1, GluN2A and GluN2B subunits and schematic (Fig. II.2.B) and
molecular (Fig. II.2.C/D) models of these regions. Results from previous studies
show that NMDA receptors crosslinked via S1-M1/S2-M4 substituted cysteines
show marked reductions in open probability and mean open time of
GluN1/GluN2A NMDA receptors (Kazi et al., 2013) that resemble effects in wild
type receptors treated with ethanol (Wright, Peoples, & Weight, 1996). On this
basis, we hypothesized that linker crosslinking would occlude ethanol inhibition of
NMDARs. As shown in Figure II.3.A, intra-subunit crosslinking of GluN1
peripheral linkers caused a modest but significant decrease in ethanol sensitivity
compared to GluN1/GluN2A wild type that was not observed with inter- or intrasubunit GluN2A linker crosslinking (two-way ANOVA with Dunnett's test; effect of
mutation, F3,87 = 5.002, p = 0.003; effect of ethanol treatment, F2,87 = 297.6, p <
0.0001; interaction, F6,87 = 0.282, p = 0.944; N = 6-10 cells). A similar subunit58

specific effect was observed with GluN2B-containing NMDARs (Figure II.3.C), as
only intra-subunit GluN1 linker crosslinked GluN1/GluN2B receptors showed a
significant reduction in ethanol sensitivity (two-way ANOVA with Dunnett's test;
effect of mutation, F3,93 = 7.232, p = 0.0002; effect of ethanol treatment, F 2,93 =
381.6, p < 0.0001; interaction, F6,93 = 2.918, p = 0.0499; N = 7-10 cells). As a
control, the sensitivity of single intra-subunit GluN1 cysteine substitutions at S549
or F810 to 100 mM ethanol was tested, and no change was observed in either
GluN2A- or GluN2B-containing receptors (GluN1/GluN2A wild type = 45.8%,
GluN1 S549C/GluN2A = 42.8%, GluN1 F810C/GluN2A = 51.4%; ANOVA; F2,25 =
3.066, p > 0.05; N = 6-10 cells: GluN1/GluN2B wild type = 55.9%, GluN1
S549C/GluN2B = 52.1%, GluN1 F810C/GluN2B = 51.5%; ANOVA; F 2,25 = 0.377,
p > 0.05; N = 6-10 cells: values reflect percent inhibition). Note that in the present
study, the wild-type GluN1/GluN2A receptors show a modest but reliable
potentiation by DTT not observed with GluN1/GluN2B receptors. This is similar to
that reported by others and is likely due to relief of tonic zinc inhibition as DTT is
an effective chelator of zinc (Kohr et al., 1994). The subunit-dependent effect of
DTT on wild-type receptor currents is consistent with the finding that GluN2Acontaining, but not GluN2B, receptors are highly sensitive to low nanomolar
concentrations of zinc found in most experimental recording solutions.
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Figure II.4: Crosslinking M1 and M4 linker domains of GluN1/2A receptors alters receptor
function. A, Mean current amplitude of GluN1/GluN2A wild type, intra-, and inter-subunit
crosslinked receptors in response to 10 uM glutamate/glycine. Bar graph shows mean amplitude
± S.E.M. of WT and mutant receptors from 6-10 cells(** p < 0.001, *** p < 0.0005; one-way
ANOVA with Dunnett’s test). B, DTT treatment enhances steady state current amplitude of
GluN1/GluN2A crosslinked receptors. Bar graph shows mean percent potentiation of current
amplitude by DTT (10 mM; 20 s) ± S.E.M. from 6-10 cells (# p < 0.05; one-sample t-test: **** p <
0.0001; one-way ANOVA with Dunnett's test). C, Schematic diagram showing location of
cysteine-substituted residues in intra- and inter-subunit M1:M4 linker crosslinked GluN1/GluN2A
receptors. D, Representative trace demonstrating potentiation of intra-GluN2A crosslinked
receptors by DTT treatment.
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Figure II.5: Crosslinking M1 and M4 linker domains of GluN1/2B receptors alters receptor
function. A, Bar graph shows mean amplitude ± S.E.M. of wild type and mutant GluN1/GluN2B
receptors from 7-10 cells (*** p < 0.0005; one-way ANOVA with Dunnett’s test). B, Effects of
DTT treatment on intra- and inter-subunit crosslinked GluN1/GluN2B receptors. Bar graph
shows mean ± S.E.M. percent potentiation of current amplitude by DTT (10 mM; 20 s) from 710 cells (# p < 0.05; one-sample t-test: **** p < 0.0001; one-way ANOVA with Dunnett’s test).
C, Schematic diagram showing location of cysteine-substituted residues in intra- and intersubunit M1:M4 linker crosslinked GluN1/GluN2B receptors. D, Representative trace
demonstrating potentiation of intra-GluN2B crosslinked receptors by DTT.

Subunit-dependent attenuation of NMDA receptor function via inhibition of S1M1/S2-TM4 linker mobility
Structural modeling and experimental evidence from the Wollmuth
laboratory shows that the S1-M1 linker of one subunit lies proximal to the
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corresponding S2-M4 linker of the other in space, and using this information, we
selected residues in GluN subunits for cysteine mutation (Sobolevsky, Rosconi,
& Gouaux, 2009; Karakas & Furukawa, 2014; Kazi et al., 2013). As shown in
Figure II.4.A, both intra- and inter-subunit crosslinking in GluN2A-containing
NMDARs produced robust decreases in current amplitude, that was rescued by a
20 second application of DTT (10 mM) indicating crosslinking of substituted
cysteines (Figure II.4.B; one-sample t-test; p < 0.05). Interestingly, the degree of
DTT potentiation of cysteine-substituted GluN2A receptors was greater for intrasubunit crosslinked receptors (~650%) than for inter-subunit receptors (~375%).
For GluN2B-containing NMDARs, however, only intra-GluN2B crosslinked
receptors and inter-subunit GluN1 M4:GluN2B M1 receptors showed an
appreciable decrease in current amplitude under non-reducing conditions (Figure
II.5.A). DTT treatment enhanced these currents with the largest DTT-induced
current potentiation, over 900%, observed for intra-subunit GluN2B receptors
(Figure II.5.B; one-sample t-test; p < 0.05).
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Figure II.6: Pre-TM4 glycine mutations in GluN1/GluN2A and GluN1/GluN2B receptors alter
glutamate potency. A, Representative traces from a GluN1/GluN2A-expressing HEK cell
showing response to 0.1 µM, 3 µM, and 30 µM concentrations of glutamate. B/C,
Concentration-response curves (B) and summary graph (C) of glutamate EC 50 values for
GluN1/GluN2A wild type and glycine-substituted mutants. Curves shown are best fits to the
equation given in Materials and methods. Bar graph shows mean ± S.E.M. EC50 values for
glutamate-activated currents in wild type and mutant GluN1/GluN2A receptors. Data for
GluN2A receptors are from 7-9 cells (* p < 0.05; one-way ANOVA with Dunnett’s test). D,
Representative traces from a GluN1/GluN2B-expressing cell showing response to 0.03 µM, 1
µM, and 10 µM concentrations of glutamate. E/F, Concentration-response curves (E) and
summary graph (F) of glutamate EC50 values for GluN1/GluN2B wild type and glycinesubstituted mutants. Curves shown are best fits to the equation given in Materials and
methods. Bar graph shows mean ± S.E.M. EC50 values for glutamate-activated currents in
wild type and mutant GluN1/GluN2B receptors. Data for GluN2B receptors are from 7-9 cells
(* p < 0.05, **** p < 0.0001; one-way ANOVA with Dunnett’s test).
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Figure II.7: Changes in glutamate
potency in response to mutation
of Pre-TM4 GluN2B residues. A,
Substitution of serine (S) 811 of
GluN2B with an alanine (A) or
aspartate (D) did not significantly
change glutamate potency, while
mutation of the preceding S810
residue to a glycine produced a
significant
leftward
shift
in
glutamate
potency.
For
comparison, the effect of GluN2B
(S811G) on glutamate potency
(data
from
Figure
5)
is
represented by the dashed line.
Data shown are mean EC50
values ± S.E.M. derived from
individual curve fits of 5-10 cells
using the equation given in
Materials and Methods (*** p <
0.001; one-way ANOVA and
Dunnett’s test). B, Substitution of
glycine at analogous positions in
GluN1 did not alter glutamate
potency, while glutamate EC50 of
GluN2B (S810G) mutant was not
affected by also substituting a
glycine at position 811. Data
shown are mean ± S.E.M. EC50
values derived from individual
curve fits of 5-10 cells using the
equation given in Materials and
Methods (* p < 0.05; one-way
ANOVA and Dunnett’s test).

Pre-TM4 residues of GluN1 and GluN2 regulate receptor function in a subunitdependent manner
The results shown in Figures II.4 and II.5 and work by others show that
restricting S2-M4 extracellular linker domain movement by disulfide crosslinking
significantly attenuates channel gating and function in GluN2A-containing
NMDARs (Kazi et al., 2013). To determine what effect increasing the flexibility of
this region has on channel activity, select residues in the Pre-TM4 region, the
terminal end of the S2-M4 linker before TM4, were mutated to the rotationally
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active glycine residue. As seen in Figure II.6, robust changes in glutamate
potency were observed in glycine-substituted mutants and these effects were
subunit-dependent. Specifically, substitution of alanine 804 to glycine (A804G) in
the Pre-TM4 of GluN1 produced a small but significant rightward shift in
glutamate potency in GluN2A-containing NMDARs that was not observed with a
mutation at the analogous serine 810 (S810G) in GluN2A (Figure II.6.B/C). This
effect persisted when GluN1 (A804G) was co-expressed with GluN2A (S810G)
(EC50 values: GluN1/GluN2A wild type = 2.18 µM, GluN1 A804G/GluN2A = 3.69
µM, GluN1/GluN2A S810G = 2.72 µM, GluN1 A804G/GluN2A S810G = 3.54 µM;
ANOVA and Dunnett's post test; F3,25 = 4.007, p < 0.05; N = 7-8 cells). For
GluN2B-containing NMDARs, however, mutation of serine 811 to glycine
(S811G) produced a profound leftward shift in glutamate potency (Figure II.6.E/F)
that was not observed in GluN1 (A804G)/GluN2B receptors. This change in
glutamate potency was eliminated by co-expression of GluN1 (A804G) (EC50
values: GluN1/GluN2B wild type = 0.90 µM, GluN1 A804G/GluN2B = 1.09 µM,
GluN1/GluN2B S811G = 0.12 µM, GluN1 A804G/GluN2B S811G = 0.78 µM;
ANOVA and Dunnett's post test; F8,67 = 9.019, p < 0.0001; N = 7-10 cells). These
effects were specific for glycine substitutions, as mutation of GluN2B S811 to
either an alanine (A) or aspartate (D) did not significantly change glutamate
potency (Figure II.7.A). Furthermore, substitution at adjacent residues in GluN1
(A803, A804) did not significantly affect the glutamate EC 50 value and adding a
second glycine residue at S810 in GluN2B did not further enhance glutamate
potency (Figure II.7.B). As a further examination of the effects of glycine
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substitutions on channel function, we used the rate of MK-801 inhibition as an
index of channel open probability (Chen et al., 1999; Hansen et al., 2013). As
shown in Table II.2, there were no significant differences in the rate of MK801
block for any of the glycine mutants tested. Table II.1 summarizes the functional
characteristics of GluN2A- and GluN2B-containing wild type and glycinesubstituted NMDARs and shows values for mean peak and steady state current
amplitude as well as a measure of macroscopic desensitization (steady state to
peak ratio).
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Figure
II.8:
Concentrationdependent inhibition of glycinesubstituted
receptors
by
ethanol. A, GluN2A (S810G)
mutant showed a significant
reduction in ethanol sensitivity
compared to wild type GluN2A.
Data shown are mean ± S.E.M.
inhibition of agonist-evoked
currents across three ethanol
doses (* p < 0.05; two-way
ANOVA with Dunnett’s test,
effect of mutation, F2,63 = 5.91,
N = 7-10 per group). B, In
contrast
to
GluN1/GluN2A
receptors,
GluN1
(A804G)/GluN2B
significantly
increased ethanol sensitivity,
with no change observed in
GluN2B (S811G) mutants. Data
shown are mean ± S.E.M.
inhibition of agonist-evoked
currents across three ethanol
doses (* p < 0.05; two-way
ANOVA with Dunnett’s test,
effect of mutation, F2,90 =
7.517, N = 7-18 per group).

Subunit-dependent
substituents

changes

in

ethanol

sensitivity

of

Pre-TM4

glycine-

Results from studies carried out by our laboratory and others have shown
that a number of sites within the TM3 and TM4 domains of GluN subunits
influence the ethanol sensitivity of NMDARs (Ronald, Mirshahi, & Woodward,
2001; Ren, Honse, & Peoples, 2003; Xu, Smothers & Woodward, 2012). To
examine whether glycine mutations in nearby Pre-TM domains also affect
ethanol inhibition, we determined the ethanol sensitivity of wild type and glycinesubstituted receptors. As shown in Figure II.8.A/B, while all wild type and glycine67

substituted GluN2A- and GluN2B-containing NMDARs displayed concentrationdependent inhibition by ethanol, there were subunit-dependent differences in
ethanol potency. For example, the GluN1/GluN2A (S810G) mutant showed a
significant reduction in ethanol sensitivity compared to GluN1/GluN2A wild type
NMDARs while this effect was not observed in GluN1 (A804G)/GluN2A receptors
(two-way ANOVA with Dunnett's post test; effect of mutation, F2,63 = 5.91, p =
0.0044; effect of ethanol treatment, F2,63 = 288.0, p < 0.0001; interaction, F4,63 =
0.1857, p = 0.1857; N = 7-10 cells). In contrast, GluN1 (A804G)/GluN2B
receptors were significantly more sensitive to ethanol, while inhibition of
GluN1/GluN2B

(S811G)

receptors

was

indistinguishable

from

that

of

GluN1/GluN2B wild type (two-way ANOVA with Dunnett's post test; effect of
mutation, F2,90 = 7.517, p = 0.001; effect of ethanol treatment, F2,90 = 262.8, p <
0.0001; interaction, F4,90 = 1.131, p = 0.347; N = 7-8 cells).
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Table II.1: Functional characteristics of GluN2A- and GluN2B-containing mutant NMDA
receptors.
Subunit/Mutant
Expressed

Rate of MK801 Block s-1
(n)

IPeak pA (n)

ISteady State pA
(n)

SS:Peak Ratio
(n)

GluN1-1a/GluN2A
WT

-927.63 ±
273.8 (8)

-462.66 ± 80.4
(8)

0.627 ± 0.073
(8)

2.99 ± 0.73 (9)

GluN1 A804G

-1064.97 ±
322.1 (7)

-453.26 ± 108
(7)

0.515 ± 0.07
(7)

3.62 ± 0.42 (8)

GluN2A S810G

-621.22 ±
193.2 (7)

-412.1 ± 114.1
(7)

0.814 ± 0.118
(7)

2.57 ± 0.58 (8)

N1 A804G/2A
S810G

-767.37 ±
231.5 (7)

-455.97 ±
159.4 (7)

0.638 ± 0.096
(7)

N.D.

GluN1-1a/GluN2B
WT

-375.01 ± 52.8
(22)

-285.65 ± 44.6
(22)

0.749 ± 0.048
(22)

1.21 ± 0.33 (9)

GluN1 A804G

-677.16 ±
207.1 (7)

-384.27 ±
113.1 (7)

0.651 ± 0.108
(7)

1.23 ± 0.26 (8)

GluN2B S811G

-186.82 ± 47.5
(10)

-119.1 ± 17.7
(10)

0.813 ± 0.102
(10)

1.60 ± 0.14 (8)

N1 A804G/2B
S811G

-724.94 ±
147.4 (7)

-328.48 ± 113
(7)

0.391 ± 0.082*
(7)

N.D.

(* denotes statistically significant deviation from wild type; one-way ANOVA with
Dunnett’s post-hoc test; * = p < 0.05; N.D. not determined)
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Table II.2: Summary of effects of selected mutations on NMDA receptor function and
ethanol sensitivity.
Crosslinke
d
Receptors

GluN1/
GluN2A
WT

IntraGluN1/
GluN2A

GluN1/
IntraGluN2A

GluN1/
GluN2B
WT

IntraGluN1/
GluN2B

GluN1/
IntraGluN2B

-413.3
pA

-178.6
pA
**

-113.9
pA
***

-221.4
pA

-273.5
pA

-69.1 pA
**

178% ↑

318.6% ↑

653% ↑
****

4.5% ↑

151% ↑

902% ↑
****

Δ Ethanol
Sensitivity

-

↓

-

-

↓

-

Glycine
Mutant
Receptors

GluN1/
GluN2A
WT

GluN1
(A804G)/
GluN2A

GluN1/
GluN2A
(S810G)

GluN1/
GluN2B
WT

GluN1
(A804G)/
GluN2B

GluN1/
GluN2B
(S811G)

Glutamate
EC50

2.2 µM

3.7 µM
*

2.7 µM

0.9 µM

1.09 µM

0.12 µM
****

Δ Ethanol
Sensitivity

-

-

↓

-

↑

-

2.99

3.62

2.57

1.21

1.23

1.6

Mean
Amplitude
(Steady
State)

DTT
Potentiation

Rate of MK801 Block
-1

(s )
NOTE: Underlined values indicate statistically significant deviations from wild type. (oneway ANOVA with Dunnett’s post-hoc test; * = p < 0.05, ** = p < 0.01, *** = p < 0.001, ****
= p < 0.0001)
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II.4 Discussion
In the present study we tested whether manipulating the mobility of
extracellular linker domains involved in regulating NMDA receptor gating and
function would significantly affect the ethanol sensitivity of the receptor. The
results show that mutations within these domains cause significant changes in
receptor gating, glutamate potency, and ethanol sensitivity that are subunitdependent. These findings highlight a disparity between the structural homology
conserved between GluN2A and GluN2B subunits and the vastly divergent
functional and pharmacological characteristics that each subunit imparts to
receptor activity. Furthermore, the data suggest that such fundamentally different
subunit-specific contributions to gating may underlie the intrinsic difference in
ethanol sensitivity previously observed between GluN2A- and GluN2B-containing
receptors (Masood et al., 1994; Mirshahi & Woodward, 1995).
Cysteine substitutions at select sites can elicit spontaneous crosslinking
and subsequent conformational locking of protein regions and this approach has
been used to probe the functional role of various domains within NMDARs
(Talukder & Wollmuth, 2011; Kazi et al., 2013). Work by the Wollmuth laboratory
used cysteine-substituted receptors that conformationally impeded S1-M1 and
S2-M4 linker movements, and these studies revealed differential contributions of
GluN1 and GluN2 linkers to receptor gating (Kazi et al., 2013). Specifically, when
kinetic data from these receptors were fit to models of NMDA receptor gating
developed by Kussius & Popescu (2009), C3-C2 and C2-C1 gating transitions
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were predominantly dictated by the GluN2A subunit (Kazi et al., 2013), while
GluN1 and GluN2 subunits made equal contributions to the final C1-O1 transition
step (Talukder & Wollmuth, 2011). The results of the DTT experiments in the
present study are consistent with this conclusion as both GluN2A- and GluN2Bcysteine-substituted receptors showed enhanced current amplitudes following
thiol reduction with the highest potentiation observed for intra-GluN2 crosslinked
receptors. While the modest potentiation observed with intra-GluN1 crosslinked
receptors may simply be due to an incomplete interaction of the cysteines, this
seems unlikely based on structural models demonstrating a high degree of
proximity of the mutated residues (Karakas & Furukawa, 2014; Xu et al., 2012).
Notably, robust whole-cell currents were obtained from intra-GluN1
crosslinked GluN2B-containing receptors that showed only slight DTTpotentiation, while intra-GluN1 crosslinking of GluN2A-containing receptors
showed significant mean current amplitude reduction with robust recovery by
DTT treatment. This finding as well as the largely homologous results seen with
inter-subunit crosslinking between receptor subtypes supports the conclusion
that GluN2-specific, not GluN1, differences likely account for subunit-dependent
disparities in DTT potentiation. This conclusion is further supported by the
change in ethanol inhibition with intra-GluN1 crosslinked receptors that occurred
regardless of the GluN2 subunit expressed. While studies have demonstrated
that GluN2A- and GluN2B-containing receptors (Erreger et al., 2005; AmicoRuvio & Popescu, 2010) exhibit substantially different channel characteristics
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including open probability, mean open time, and glutamate dissociation rate,
work by the Wollmuth laboratory (Kazi et al., 2013) first discriminated unequal
contributions of the GluN1 and GluN2 subunits within GluN2A-containing
NMDARs to receptor gating. Our results thus raise the intriguing possibility that
intrinsic proportional contributions of GluN1 and GluN2 to gating are themselves
fundamentally different between GluN2A- and GluN2B-containing NMDARs, and
could underlie the divergent gating profiles observed between the receptor types.
As a counterpoint to the crosslinking experiments, we generated S2-M4
glycine mutants to increase the intrinsic flexibility of this region. Substitution or
addition of glycine residues within discrete regions of ion channels including the
NMDAR has been shown to enhance movement and function of these channels
(Kellenberger et al., 1997; Kazi et al., 2014). When the changes in glutamate
potency of glycine mutants are compared between receptor subtypes, it becomes
apparent that glycine substitution reveals fundamental differences in the
contribution of S2-M4 linkers to channel function that are not fully resolved with
cysteine crosslinking. As observed with GluN2A-containing receptors, glycine
substitution in the S2-M4 of GluN2A results in no demonstrable change in
glutamate potency, while glycine substitution in the S2-M4 of GluN1 produces a
significant decrease in glutamate potency that persists upon co-expression of a
glycine-substituted GluN2A. In contrast, glycine substitution in the S2-M4 of
GluN2B produces a profound increase in glutamate potency that is nullified by
co-expression of the GluN1 (A804G) subunit, while GluN1 (A804G)/GluN2B
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receptors show no discernable change. At first blush it seems curious that
changing the intrinsic flexibility of the glycine-binding GluN1 subunit would alter
the potency of the receptor for glutamate, or in the case of GluN2B (S811G)
receptors, restore glutamate potency to wild type levels. Others, however, have
shown that the GluN2 subunit can similarly impact the glycine potency of
NMDARs in a subunit-dependent manner (Chen et al., 2008) suggesting a
reciprocal interaction between subunits.
The observed disparity between the effects of glycine substitution on
glutamate potency in GluN2A- and GluN2B-containing receptors, when
considered in light of results from crosslinking experiments, implies nonhomologous, subunit-specific contributions to receptor function. Indeed, studies
have shown that GluN2A-containing NMDARs exhibit a much higher open
probability compared to GluN2B-containing receptors (Erreger et al., 2005;
Gielen et al., 2009; Hansen et al., 2013) and the results of the MK-801 blocking
experiments in the present study reflect these intrinsic differences. These
subunit-dependent differences in open probability appear to be attributable, at
least in part, to interactions between the amino terminal domain (ATD) and ligand
binding domains (LBD) that affect spontaneous opening and closure of the ligand
binding cleft in GluN2 subunits (Gielen et al., 2009). The high sequence
homology of core transmembrane gating elements between the GluN2 subunits
further supports this ATD-LBD interaction model. Based on these findings, we
posit that the lack of effect on glutamate potency observed for GluN2A S2-M4
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glycine mutants is due to a ceiling effect on gating, in which actions of the ATD
on activity of the ligand binding domain precludes any mutation-induced
facilitation of the steps between agonist binding and channel gating. However,
due to the much lower opening probability of GluN2B NMDARs, possibly
reflective of subunit differences in ATD-LBD interactions, facilitating agonist
activity by increasing the flexibility of the S2-M4 linker profoundly increases
glutamate potency. In addition, this change is likely not simply due to increased
spontaneous movement of core gating elements, as there was no change in the
rate of MK-801 block in glycine-substituted mutants. Indeed, results from the DTT
experiments support this conclusion as intra-GluN2B crosslinked receptors
showed a significantly larger potentiation of current over intra-GluN1 crosslinked
GluN2B receptors compared to GluN2A-containing receptors. Thus, we conclude
that mechanistically, the S2-M4 region acts as a significant element in
transduction of agonist binding to channel gating in GluN2A- and GluN2Bcontaining NMDARs and that manipulation of the flexibility of this region reveals
a substantially higher contribution to channel gating of the GluN2 subunit in
GluN2B-containing NMDARs compared to GluN2A-containing NMDARs.
The primary goal of the present study was to determine if manipulation of
S2-M4 linker flexibility would elucidate mechanisms of ethanol action on NMDAR
function distinct from core transmembrane sites. While others have shown that
GluN1 M3/GluN2 M4 residue interactions are non-homologous to GluN1
M4/GluN2 M3 interactions in defining ethanol sensitivity (Ren et al., 2012), the
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hypothesis underlying this study nevertheless initially rested on the assumption
that the mechanisms of gating between GluN2A- and GluN2B-containing
receptors were largely homologous. The functional data presented, though,
argue against this assumption and indeed results from the ethanol experiments
further support this conclusion. Specifically, a significant decrease in ethanol
sensitivity was observed in GluN2A (S810G) receptors but not GluN1
(A804G)/GluN2A receptors. The opposite was observed with GluN2B-containing
receptors, though, as a significant increase in ethanol sensitivity was observed
only with GluN1 (A804G)/GluN2B receptors. As the amino acid sequence of the
S2-M4 is identical between GluN2A and GluN2B subunits, it was predicted that
either constraining (via cysteine-substitution) or enhancing (via glycinesubstitution) S2-M4 linker mobility would elicit similar effects on ethanol
sensitivity of GluN2A- and GluN2B-containing NMDARs. The subunit-dependent
effects of glycine-substitution on ethanol sensitivity observed in the present study
agree with emerging findings (Zhao et al., 2015) and suggest that ethanol does
not impede receptor gating of GluN2A- and GluN2B-containing receptors in a
homologous manner, perhaps as a consequence of the fundamentally different
contributions of individual GluN2 subunits to channel activity. In sum, we
demonstrate, in agreement with others, that extracellular linker domains of GluN
subunits are significant elements in the transduction cascade between agonist
binding and pore opening and that differential modulation of the mobility of these
regions reveal fundamental differences in GluN2 subunit contributions to receptor
gating. Furthermore, the subunit-specific effects on ethanol sensitivity, though
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modest, reported herein argue that intrinsic differences in ethanol sensitivity
between GluN2A- and GluN2B-containing receptors may largely be a
consequence of essential differences in gating between the receptor types
instead of different structural sites of action.
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Chapter III. Secondary Mechanisms of NMDAR Inhibition by Ethanol
III.1 Introduction
As discussed in Section I, the NMDA receptor is a critical link between
neuronal excitation and the adaptive processes that drive synaptic strengthening
and depression. The direction and intensity of NMDAR-mediated synaptic
alterations is largely a product of what GluN2 subunit-containing NMDARs are
predominantly activated, with extensive evidence suggesting GluN2B-containing
receptors exhibit the most robust predilection for inducing neuroadaptive
responses. Importantly, the NMDA receptor is a primary site of action for the
inhibitory effects of ethanol, and such inhibition correlates strongly with
behaviorally relevant doses of alcohol impairing known NMDAR-mediated
phenomena including learning and memory. While our laboratory and others
have identified a number of sites within the core membrane-spanning elements
of the receptor as sites of alcohol action, emerging evidence suggests that intermolecular interactions between the receptor and secondary effector proteins
could also mediate ethanol-induced reductions in NMDAR current.
Among these studies are reports of physiologically relevant doses of
ethanol inducing activity of striatal-enriched protein phosphatase (STEP) that
appears to interact specifically with GluN2B-containing NMDARs and promotes
internalization of the receptor complex (Alvestad et al., 2003; Wu et al., 2010;
Hicklin et al., 2011). This schema is based on work previously showing that
extreme C-terminal tyrosine (Y) residues on GluN2B, e.g. Y1472, can signal
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clathrin-mediated

internalization

of

the

receptor

complex

based

on

phosphorylation state (Roche et al., 2001; Prybylowski et al., 2005). In Hicklin et
al. (2011) the authors observed a consistent reduction in phosphorylation of
residue Y1472 on GluN2B with ethanol treatment that correlated with receptor
internalization and STEP activity. Importantly, the authors showed that with
knockdown of STEP protein, cultured neurons displayed ethanol resistance as
well as curtailed GluN2B-containing NMDAR internalization. Indeed, when
considered with data correlating heightened GluN2B-containing NMDAR surface
expression with ethanol resistance, such a mechanism of sustained ethanol
inhibition of NMDAR-mediated currents becomes viable (Wang et al., 2007).
While attractive, it nevertheless remains unclear as to whether such
differential phosphorylation of C-terminal tyrosine residues on GluN2B contribute
to ethanol sensitivity strictly via receptor internalization or if the phospho-state of
these residues can directly impact receptor function. Initial studies seeking to
understand the effect of phosphorylation on AMPAR currents seemed to show
that post translational modification of C-terminal amino acids could regulate
receptor function directly (Raymond et al., 1993). Indeed, later work with the
NMDA receptor appeared to show that differential phosphorylation of single
residues within the C-termini of GluN2 subunits was sufficient to alter ion
permeability and receptor desensitization at the single channel level (Murphy et
al., 2014; Aman et al., 2014). Thus, in the present study we sought to determine
if the phosphorylation state of three C-terminal tyrosine residues on GluN2B
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previously shown to be robust sites of STEP activity could alter the intrinsic
ethanol sensitivity and receptor function of recombinantly expressed NMDARs. If
dephosphorylation of these tyrosines represents a key step in the inhibition of
channel

currents

by

alcohol,

then

rendering

these

sites

permanently

dephosphorylated should mimic ethanol inhibition and occlude any further action
of ethanol.
III.2 Methods
Cell Culture and Transfection
Human embryonic kidney (HEK) 293 cells were obtained from ATCC
(Manassas, VA) and maintained in 10 cm culture dishes containing serumsupplemented DMEM in a humidified incubator with 5% CO2. Cells were split
every 48 hours. For recordings, cells were split on poly-ornithine coated 35 mm
dishes and 24 hours later transfected using Lipofectamine 2000 reagent
(Invitrogen Inc, Carlsbad, CA). Plasmids containing rat GluN1, wild-type or
mutant rat GluN2B, and an enhanced green fluorescent protein for cell selection
were transfected at a 2:2:1 ratio unless otherwise noted. Mutant receptors were
generated using the Quik Change II site-directed mutagenesis kit (Agilent
Technologies, Santa Clara, CA) and nucleotide substitutions were verified via
sequencing (Genewiz, South Plainfield, NJ). Prior to transfection, media was
exchanged with fresh serum-supplemented DMEM containing 0.5 mM AP5 to
prevent glutamate-mediated excitotoxicity (Cik et al., 1994). AP5 was removed
by extensive washing prior to recording.
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Electrophysiology
Dishes containing transfected cells were mounted on an Olympus IX50
inverted microscope and perfused with an extracellular recording solution at a
rate of 1-2mL/min. Extracellular recording solution contained the following (in
mM); NaCl (135), KCl (5.4), CaCl2 (1.8), HEPES (5), glucose (10), (pH adjusted
to 7.4 with 1M NaOH, and osmolarity adjusted to 315-325 mOsm with sucrose).
Patch pipettes (2-4 MOhms) were pulled from standard wall borosilicate glass
(1.5 x 0.85 mm) and filled with internal solution containing the following (in mM);
CsCl (140), MgCl2 (2), EGTA (5), HEPES (10), NaATP (2), NaGTP (0.3), (pH
adjusted to 7.2 with 2M CsOH, and osmolarity adjusted to 290-295 mOsm with
sucrose). Transfected cells were identified by eGFP fluorescence and whole-cell
voltage clamp recordings were performed at room temperature using an Axon
Instruments 200B microamplifier (Molecular Devices, Union City, CA). Cells were
held at -70 mV to monitor breakthrough and maintained at this potential unless
otherwise

noted.

Whole-cell

capacitance

and

series

resistance

were

compensated for and access resistance was monitored throughout the
experiment. Cells demonstrating unstable holding currents or significant changes
in series resistance were excluded from analysis. NMDA currents were evoked
using a Warner FastStep multi-barrel perfusion system programmed to switch
between extracellular recording solution and solution containing agonist (10 µM
glutamate and glycine) or agonist plus ethanol (10-600 mM). Glutamate doseresponse curves were established using a similar method by increasing the
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concentration of glutamate from 0.03-10 µM. The order of solutions was
interleaved to monitor current rundown and changes >15% were excluded from
analysis. For current-voltage

relationship experiments,

stable

whole-cell

configurations were first established at -70 mV, after which cells were held at 0
mV. Extracellular solution containing agonist and MgCl2 was then washed on and
the cell was subjected to a ramp protocol consisting of a jump to -80 mV, a 1.3
sec ramp to +80 mV, and a return to 0 mV holding potential. This protocol was
repeated three times and I-V curves were obtained from the average of the three
traces. All data were filtered at 1-2 kHz and acquired at 5 kHz using an Instrutech
ITC-16 digital interface (HEKA Instruments, Bellmore, NY) and analyzed offline
by Axograph X software (Axograph Scientific, Sydney, NSW, Australia).
Data Analysis
Data are expressed as mean ± SEM and were analyzed by analysis of
variance using Prism 5.0 software (Graphpad Software, San Diego, CA) where
indicated. Concentration-response curves for ethanol and glutamate were
analyzed using non-linear regression. Not all ethanol concentrations could be
tested on each cell thus preventing using Prism to calculate individual IC50s for
each cell. Instead for these data, a two-parameter (slope and EC50) logistic
function was estimated for all curves using SPSS (IBM Corporation, Armonk, NY)
and individual curve IC50s were then analyzed for group differences via ANOVA.
Preliminary analysis indicated that slopes were not different and all curves for
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each group were estimated simultaneously with shared logistic slopes. For all
analyses, statistical significance was set at p<0.05.
III.3 Results

Figure III.1: Schematic cartoon of the NMDA GluN2B subunit. The extracellular N-terminus,
four transmembrane domains denoted by the four blue boxes, and the intracellular C-terminus
are depicted in the diagram. Red circles on the intracellular C-terminus indicate the
approximate location of tyrosine residues 1252, 1336, and 1472. Also depicted are
comparisons of wild-type (top) and mutant (bottom) amino acid sequences for each mutation
studied.

Figure III.1 shows a schematic of the GluN2B subunit, highlighting the Nterminal domain, the glutamate binding site, transmembrane domains, and the
intracellular C-terminal region of the GluN2B subunit. Residues that were
mutated from tyrosine to phenylalanine were at positions 1252, 1336 and 1472 of
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the full length rat GluN2B subunit. Wild-type and mutant GluN2B constructs were
co-expressed with GluN1-1a subunits in HEK293 cells and whole-cell patch
clamp electrophysiology was used to determine the sensitivity of ethanol.

Table III.1 summarizes the functional characteristics of wild-type and
mutant receptors in terms of peak and steady-state amplitude and the steadystate to peak ratio, a marker of macroscopic receptor desensitization. While no
significant differences were observed between wild-type and mutant receptors for
peak current amplitude, one-way ANOVA revealed an overall significant effect
between groups for steady-state current amplitude and steady-state to peak ratio
(f(4,119)=2.2694, p=0.034; f(4,119)=2.729, p=0.032 respectively). Post-hoc
analysis using Bonferroni and Dunnett’s tests, however, demonstrated no
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significant differences between wild-type and mutant receptors for either
parameter.

Figure III.2: Concentration-response relationship for glutamate activation of mutant and wildtype GluN2B-containing NMDARs. (A) Example traces showing currents from wild-type
NMDAR transfected cell during exposure to to 0.03 μM (black), 1 μM (light blue), and 10 μM
glutamate (dark blue). (N = 6 - 8 cells). All recordings performed in the presence of 10 µM
glycine. (B) Currents are expressed as percent of maximal response to various concentrations
of glutamate (0.03-10 μM). Non-linear regression yielded EC50 values of 0.92 μM (wild-type),
0.88 μM (Y1472F), 0.95 μM (Y1336F), 0.78 μM (Y1252F), and 0.69 μM (triple mutant). Inset
bar graph shows a comparison of ln EC50 values expressed as mean ± SEM.

To determine whether manipulation of the three tyrosine residues altered
the receptor’s affinity for agonist, concentration-response curves for glutamate
were generated. As shown in Figure III.2, increasing concentrations of glutamate
evoked increases in whole-cell current in both wild-type and mutant receptors.
Nonlinear regression analysis revealed no significant difference in glutamate
affinity for any of the mutants tested. Calculated EC50 values for glutamate were
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0.92 μM (wild-type), 0.88 μM (Y1472F), 0.95 μM (Y1336F), 0.78 μM (Y1252F),
and 0.69 μM (triple mutant). ANOVA revealed no significant differences between
groups for glutamate EC50 values (f(4,27)=0.822, p=0.523).

Figure III.3: Current-voltage relationship of wild-type and phospho-mutant NMDARs. (A) Cells
were voltage clamped at 0 mV and then stepped to -80 mV for 200 ms followed by a 1.3s
ramp to +80 mV for another 200 ms before returning to 0 mV. All recordings were performed
in the presence of 2 mM Mg++. (N = 7 – 9 cells) (B) Current-voltage relationship of wild-type
and mutant receptors after normalizing current to that obtained at +80 mV.

As a follow-up to the agonist dose-response experiments, the effect of
tyrosine mutations on the voltage-dependent magnesium block of NMDA
receptors was also determined. Figure III.3.A shows glutamate-evoked currents
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in the presence of 2 mM Mg++ in cells held at different membrane potentials. In
these studies, the concentrations of glutamate and glycine were held at 10 µM
and current amplitude was expressed as a function of cell capacitance. Analysis
of the current-voltage relationship revealed no significant differences between
wild-type and mutants receptors although overall amplitudes did tend to vary. To
account for this variability, I/V curves generated in each cell were normalized to
the amplitude measured at +80 mV where Mg block is minimal. Figure III.3.B
shows these normalized data and confirms there were no differences in voltagedependent block between wild-type and mutant receptors.

Figure III.4: Concentration-response effect of ethanol on wild-type and mutant GluN2Bcontaining NMDARs. (A) Example traces from a cell expressing wild-type and mutant GluN2B
receptors. Agonist-only (blue) current; agonist + 100 mM EtOH (black). (B) Data are
expressed as percent inhibition by ethanol (10-600 mM) of glutamate-evoked currents. (N = 6
– 8 cells per concentration). Non-linear regression yielded estimated IC 50 values for ethanol of
136 mM (wild-type), 135 mM (Y1472F), 118 mM (Y1336F), 104 mM (Y1252F), and 156 mM
(triple mutant). Inset bar graph shows a comparison of ln IC 50 values expressed as mean ±
SEM.
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Finally, the effect of a series of ethanol concentrations on glutamateactivated currents was determined for wild-type and mutant receptors. In these
studies, currents were evoked with 10 µM glutamate/glycine in the absence or
presence of ethanol (10-600 mM). As shown in Figure III.4, ethanol caused a
concentration-dependent inhibition of wild-type and mutant receptors. At the
lowest concentration tested (10 mM), currents were inhibited by approximately 515% while 600 mM ethanol completely eliminated NMDA receptor currents. In
fact, in all receptors tested, 600 mM ethanol resulted in slightly greater than
100% inhibition due to the presence of outward currents at this concentration.
These currents may have resulted from ethanol’s inhibition of leak current or from
the slight change in ionic strength (~4%) produced when preparing the 600 mM
ethanol solution. To examine these possibilities, non-transfected cells were
voltage-clamped at -70 mV and holding currents were monitored before and
during administration of ethanol. At a concentration of 600 mM, ethanol produced
outward currents in non-transfected cells with an average amplitude of 11.63 pA
± 5.25 pA (mean ± SEM). No such effect was observed when ethanol was
replaced with water suggesting that ethanol’s effect on holding current was due
to inhibition of a leak current and not a change in ionic strength. To account for
this effect, the mean amplitude of the outward current measured in nontransfected cells was subtracted from the currents obtained in transfected cells
during exposure to 600 mM ethanol. Regression analysis of the ethanol
concentration-response curves yielded estimated IC50 values of 136 mM for wildtype, 135 mM for Y1472F, 118 mM for Y1336F, 104 mM for Y1252F, and 156
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mM for the triple mutant. There were no significant differences between groups
for ethanol IC50 (f(4,86)=1.48, p=0.215).
III.4 Discussion
In the present study, site-directed mutagenesis and whole-cell patchclamp electrophysiology were used to examine the ethanol sensitivity of
recombinant NMDARs with mutations that mimic permanently dephosphorylated
tyrosine residues implicated in the inhibitory actions of ethanol. All mutant
receptors tested in HEK293 cells showed robust glutamate-activated currents
and all mutants retained wild-type like sensitivity to ethanol. The results of this
study strongly suggest that dephosphorylation of these C-terminal tyrosine
residues does not mediate the acute inhibitory actions of ethanol on recombinant
NMDARs. They also suggest that ethanol inhibition of NMDA receptors
expressed in native neurons is not solely due to dephosphorylation at these sites
as has been suggested from studies in brain slices (Wu et al., 2010; Hicklin et al.,
2011). Indeed, it is more likely that the phosphorylation state of these residues
may represent intermediate sites of regulation in a larger cascade of events that
are induced during long exposures to ethanol.
NMDA receptors are subject to tyrosine phosphorylation and the Srcfamily kinase Fyn is highly enriched in neurons where it associates with GluN2Bcontaining NMDARs. Over-expression of a constitutively active form of Fyn
kinase in cerebellar granule cells resulted in robust increases in NMDA miniEPSCs with little change in overall kinetics, suggesting increased membrane
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insertion of NMDARs (Prybylowski et al., 2005). Co-expression of Fyn kinase
with recombinant NMDA receptors to enhance tyrosine phosphorylation had no
effect on the ethanol sensitivity of GluN1/GluN2B currents, supporting the
hypothesis that changes in NMDAR currents observed in neuronal tissue by Fyn
is due to altered trafficking (Kohr and Seeburg, 1996; Anders et al., 1999). Work
conducted by Nakazawa et al. (2001) further showed that Fyn preferentially
phosphorylates residues Y1252, Y1336, and Y1472 on GluN2B.
The interaction of Fyn kinase with GluN2B receptors is highly brain region
dependent. Work by Yaka et al. (2003) showed that compartmentalization of Fyn
with NMDARs occurs prominently in hippocampus and dorsal striatum but not in
cerebral cortex. This interaction requires the scaffolding protein RACK1 and
enhanced scaffolding of Fyn and GluN2B via RACK1 during ethanol exposure
allows for increased membrane insertion of GluN2B-containing NMDARs,
resulting in enhanced currents and the development of a functional form of acute
ethanol tolerance (Wang et al., 2007; Wang et al., 2010). This mechanism is
consistent with the lack of acute ethanol tolerance at the electrophysiological and
behavioral level observed in Fyn-deficient mice (Miyakawa et al., 1997).
While activation of Fyn and enhanced NMDAR membrane trafficking may
compensate for reduced NMDA signaling during acute ethanol inhibition, recent
data from other laboratories suggests that dephosphorylation of key GluN2B
tyrosine residues by striatal enriched protein phosphatase (STEP) may directly
underlie the inhibitory actions of alcohol. STEP is abundantly expressed in the
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striatum and hippocampus, and associates with GluN2B-containing NMDARs
(Pelkey et al., 2002). It has been hypothesized that STEP mediates the inhibitory
actions of ethanol on NMDARs by dephosphorylating Y1472 on the C-terminus of
GluN2B. Using a phospho-Y1472 GluN2B antibody, Wu et al. (2010)
demonstrated a significant reduction in immunoreactivity in hippocampal slices
following acute administration of 80 mM ethanol. Further work showed that mice
lacking STEP showed no change in the phosphorylation of Y1472 following
ethanol administration (Hicklin et al., 2011). Inhibiting STEP with dominantnegative peptide eliminated ethanol inhibition of NMDAR-mediated EPSCs in
hippocampal slices. Interestingly, however, a compensatory rebound in NMDAR
current was observed after washout of ethanol in these experiments, likely due to
the activity of Fyn (Yaka et al., 2003).
In the present study, mutating Y1472 to phenylalanine in order to mimic a
permanently dephosphorylated state had no effect on ethanol sensitivity or
channel function of recombinant GluN2B receptors. These results are consistent
with prior work by our laboratory that found co-expression of various kinases
including c-Src and Fyn also had no effect on the ethanol sensitivity of
recombinant GluN2B-containing NMDARs, despite significant enhancement of
tyrosine phosphorylation of these subunits (Anders et al., 1998; Anders et al.,
1999). Results from recombinant and brain slice studies instead suggest that
acute administration of ethanol likely induces multiple effects. First, ethanol
directly inhibits channel function on a sub-second time scale, perhaps by
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interacting with regions of GluN1 and GluN2 subunits that are involved in
receptor gating (Ren et al., 2012; Ronald et al., 2001; Smothers and Woodward,
2006; Xu et al., 2011). Next, via an unknown mechanism, STEP is activated and
preferentially recruited to GluN2B subunits where it dephosphorylates Y1472,
promoting their removal from the post-synaptic density and internalization
(Hicklin et al., 2011; Prybylowksi et al., 2005). Finally, ethanol-induced activity of
Fyn via Rack1 scaffolding compensates for STEP-induced internalization,
producing enhanced surface expression of NMDARs that is revealed following
ethanol washout (Wang et al., 2007). Such a scenario may exist in brain regions
such as hippocampus and striatum where STEP and Fyn prominently associate
with GluN2B-containing NMDARs. Other brain areas such as cortex that do not
show robust interactions with STEP and Fyn show significant inhibition of NMDAmediated EPSCs without evidence of a rebound in NMDA EPSCs following
cessation of ethanol exposure.
In summary, the results of this study show that the phospho-state of key
C-terminal tyrosine residues of the GluN2B subunit does not directly regulate
ethanol sensitivity. Rather, these residues likely influence apparent ethanol
sensitivity via alterations in the trafficking and surface expression of GluN2Bcontaining NMDARs. Such data demonstrate that the actions of ethanol are
myriad and complex and may modulate NMDAR activity through a number of
different mechanisms.
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Chapter IV: Mechanisms of Triheteromeric GluN1/GluN2A/GluN2B NMDA
Receptor Regulation
IV.1 Introduction
As discussed in previous sections, NMDA receptors can exhibit vastly
different kinetic profiles as well as highly idiosyncratic intermolecular signaling
cascades depending on the GluN2 subunit subtype being studied. Due largely to
the high fidelity of many subtype-specific pharmacological agents such as
ifendprodil and TCN-201, much of the work teasing out the role of different
NMDA receptor subtypes in neuronal function has necessarily probed “pure”
diheteromeric populations. In these studies, receptors are composed of two
obligate GluN1 subunits and two copies of the same GluN2 subtype (e.g. 2A)
arranged in a 1:2:1:2 orientation. However, evidence including that from early
studies of NMDA receptor expression has suggested that triheteromeric NMDA
receptors containing two different GluN2 subunits exist and may even
predominate in some brain areas (Wafford et al., 1993; Dunah et al., 1996).
Indeed, by exploiting intrinsic receptor properties such as differential magnesium
sensitivity between GluN2A- and GluN2B-containing NMDARs in tandem with
sub-maximal concentrations of subtype specific antagonists, researchers have
parsed out unique pharmacological and kinetic profiles of triheteromeric
NMDARs that appear to better model the NMDA-dependent signaling dynamics
observed at synapses (Rauner & Kohr, 2011; Tovar, McGinley, & Westbrook,
2013).
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While the method described above has proven effective at generally
probing the idiosyncratic nature of triheteromeric NMDARs, “cleanly” isolating a
population of triheteromers for study, even in recombinant expression systems,
has remained a challenge. Recently, however, two research groups working
independently established a method that took advantage of the complementary
retention motifs on GABAB1 and GABAB2 subunits that drive dimerization of
native GABA-B receptors. These motifs were cloned onto the ends of cDNAs
encoding GluN2A and GluN2B in order to bias expression of a triheteromeric
GluN1/GluN2A/GluN2B receptor conformation in oocytes (Terunuma, Pangalos,
& Moss, 2010; Hansen et al., 2014; Stroebel et al., 2014). Exploitation of this
phenomenon has not only confirmed the unique signaling characteristics of
triheteromeric NMDARs observed by Rauner and Kohr (2011), but has enabled
researchers to now study the effects of a vast array of pharmacological agents,
on this heretofore neglected receptor population. As outlined in Section II,
assumptions of congruent action of alcohol on different GluN2-containing
receptors have proven untenable, suggesting the intriguing possibility that
ethanol could exhibit substantially different actions on triheteromeric NMDARs
both at the level of channel function as well as the novel signaling cascades
these receptors may govern.
At the most basic level, though, significant questions remain regarding the
intrinsic regulation of these novel receptors. Specifically, it remains unknown
exactly what factors drive the preferential expression of N1/2A/2B triheteromeric
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receptors at the synapse. While the process of diheteromer vs. triheteromer
sorting could be stochastic and simply driven by cell-specific differences in
subunit expression, experiments have shown that the magnitude of the surface
expression of GluN3-containing NMDARs is critically dependent on what GluN1
splice variant is present (Smothers & Woodward, 2009). Indeed, GluN1 splice
variants are determined primarily by alternating inclusion/exclusion of C-terminal
cassettes averages ~20 amino acids in length that contain differential retention
motifs and can affect intrinsic channel properties such as receptor desensitization
and calcium permeability (Traynelis et al., 2010). GluN1 subunits are further
discriminated as “A” or “B” type variants depending on the absence or presence
of an N-terminal stretch of amino acids, known as Exon 5, and can affect
receptor complex assembly within the ER (Meddows et al., 2001; Qiu et al.,
2009).

From: Smothers & Woodward (2009)

In addition, Clapp et al. (2010) observed a significant upregulation of C2’
cassette-containing GluN1 splice variants following chronic ethanol exposure.
Considering that GluN1 splice variants are defined by the presence or absence
of differential endoplasmic reticulum retention motifs, this phenomenon implies
that NMDA receptors undergo directed, GluN1-subtype specific sorting prior to
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insertion into the plasma membrane. Furthermore, data has shown that at the
level of the endoplasmic reticulum, GluN1 and GluN2 subunits exhibit directed
assembly, to the extent that only fully complemented tetramers are allowed to
exit and traffic to the plasma membrane (Riou et al., 2012). Taken together, this
data and the enriched presence of triheteromers at the synapse suggests that
triheteromeric NMDA receptors likely exhibit some form of directed sorting prior
to insertion into the plasma membrane, and that such sorting may be critically
dependent on the expression of GluN1 splice variants. The profound GluN1 and
GluN2 subtype-specific expression changes of NMDA receptors by ethanol
exposure outlined above and in Section I thus suggest triheteromeric NMDA
receptor populations may be similarly affected. Thus, we hypothesize that altered
expression of GluN1 splice variants after ethanol exposure represents a
mechanism for altered triheteromeric NMDAR expression. To test this
hypothesis, HEK 293 cells were tranfected with cDNAs expressing GluN2A-YFP
and GluN2B-R.Luciferase (Rluc) along with one of the eight different GluN1
splice variants. We then used bioluminescence resonance energy transfer
(BRET) to evaluate the intrinsic association of GluN2A and GluN2B subunits
within the same receptor complex.
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Figure IV.1: Figure depicts the experimental basis of BRET. Luciferase from Renilla
reniformis (Rluc; R) decarboxylates coelenterazine and as a by-product releases light at the
480 nm wavelength. If Rluc comes into proximity (e.g. within 100 Angstroms) with a
fluorescent protein like yellow fluorescent protein (YFP; Y), such as in an NMDA receptor
complex, the photon released by coelenterazine digestion will instead undergo resonance
energy transfer and be emitted in the longer wavelength YFP emission spectrum. This BRETmediated YFP emission can then be quantified and compared between GluN1 splice variant
expression groups, allowing the experimenter to determine the relative rates of
triheteromerization between these groups.
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IV.2 Methods
Cell culture and BRET
In brief, HEK-293 cells were maintained in 10 cm culture dishes with 10%
serum-supplemented DMEM in a humidified incubator supplied with 5% CO2 and
split every other day. Fusion proteins were generated by cloning an enhanced
yellow fluorescent protein (YFP) cDNA onto the C-terminus of GluN2A and a
bioluminescent luciferase from Renilla reniformis onto the C-terminus of GluN2B.
For experiments, cultures were plated onto 6-well plates and transfected with
GluN1, GluN2A-YFP, and GluN2B-Rluc at a 2:1:1 ratio using Lipofectamine 3000
(Invitrogen; Carlsbad, CA) reagent. The culture medium was supplemented with
0.5 mM AP5 (Abcam; Cambridge, MA) to prevent excitotoxic cell death, and
experiments were performed 24 hours after transfection. Bioluminescence
resonance energy transfer (BRET) experiments were conducted according to
procedures outlined in Oner et al. (2010). Briefly, cells were washed once with 1x
phosphate-buffered saline and harvested with Tyrode’s solution containing (in
mM): NaCl 140, KCl 5, CaCl2 2, NaH2PO4 0.37, NaHCO3 24, HEPES 10, and
0.1% glucose (w/v) (pH adjusted to 7.4 with NaOH). Cells were distributed in
triplicate into gray 96-well optiplates and all fluorescence/luminescence signals
measured using a TriStar LB 941 plate reader (Berthold Technologies, Oak
Ridge, TN). The luciferase substrate Coelenterazine H (3 uM final concentration)
was added for 2 min after which luminescence was measured (donor, 480 ± 20;
acceptor, 530 ± 20 nm). BRET was defined as the ratio of 530 ± 20/480 ± 20,
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and net BRET values were obtained by subtracting the background signal
detected from expression of cells expressing the Rluc-tagged construct alone.
Data analysis
Statistical comparisons including one-way and two-way Analysis of
Variance were conducted using Prism 6.0 (Graphpad Software, Inc., San Diego,
CA).
IV.3 Results

Figure IV.2: Analysis of Net BRET values between GluN2A-YFP and GluN2B-Rluc reveals
that the presence of GluN1 results in a significant reduction in BRET signal for all variants
except GluN1-1a. (* = p < 0.001, two-way ANOVA with Bonferroni’s post hot test; interaction
p < 0.05, F4,100 = 2.725; experimental condition p < 0.001, F4,100 = 5.102; splice variant p <
0.0001, F1,100 = 69.19)

BRET Reveals GluN1 Splice Variant-Independent Triheteromeric Assembly
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In Figure IV.2, BRET values were compared between GluN1+ and GluN1experimental groups among the different splice variants. With the exception of
GluN1-1a, all other splice variants including the mutant GluN1-6A exhibited a
significant decrease in net BRET signal compared to net BRET values of
observed in the absence of GluN1 expression. As discussed in Stroebel et al.
(2014), the GluN1-6A mutant has six key C-terminal residues that were mutated
to alanines, thus nullifying the high fidelity ER retention motifs normally present in
the wild-type GluN1-1a variant. The reduction in BRET with GluN1-6A and lack of
such an effect with the wild-type variant thus likely reflects alterations in the
degree of ER retention between these two variants. The inclusion of a GluN1lacking experimental condition (hashed bars in Figure IV.2) stems from work by
Qiu et al. (2005) showing that GluN2 subunits will spontaneously co-assemble in
the absence of GluN1 within the ER, and thus provides both an estimate of
BRET signal generated by GluN1-independent assembly and a control condition
that different GluN1 subtype expressing groups can be normalized against. From
this data it is inferred that, while a significant population of triheteromers are likely
being assembled, diheteromeric populations are assembled as well although to a
lesser degree. While these results cannot definitively rule out the possibility that
the decrease in BRET is simply an artifact of higher surface area of the plasma
membrane relative to the ER resulting in reduced random BRET signal, this is
unlikely as there is no correlation between signal intensity and expression levels
of GluN2A-YFP and GluN2B-Rluc (Figure IV.5) and in fact such data argues
instead for specificity of the observed signal. Additionally, changes in BRET
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signal may be due to presence of GluN1 driving YFP and Rluc apart, leading to
an interpretation in which reduction in BRET signal instead implies enhanced
triheteromerization. This possibility cannot be ruled out with the data presented,
although co-immunoprecipitation of GluN2A and Western blotting for GluN2B can
verify that the BRET signal genuinely reflects complexed GluN2A/GluN2B
subunits.
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Figure IV.3: By taking a ratio of GluN1+ to GluN1- net BRET, we see that all splice variants
except GluN1-1a exhibit a significant decrease in signal likely reflective of reduced
association of GluN2A-YFP and GluN2B-Rluc as the fully complemented receptors are
trafficked out of the ER and to the membrane. Indeed, it is inferred that since a reduction in
signal is observed with the GluN1-6A mutant that significant retention of receptors in the ER
is occurring with the GluN1-1a variant. (* = p < 0.01; One-way ANOVA with Tukey’s post hoc
test; F4, 50 = 7.858)

When normalized to GluN1-lacking values, the data appear to show that
triheteromeric GluN1/GluN2A/GluN2B receptors constitute nearly 75% of the
receptor pool as shown in Figure IV.3. Importantly, however, triheteromericity
seems to occur irrespective of GluN1 splice variant type. Furthermore as shown
in Figure IV.4, expressing the “B” GluN1 variants that contain the N-terminal
Exon 5, appears to have no effect either on triheteromeric assembly or
trafficking. Thus, it appears that triheteromeric expression occurs regardless of
the GluN1 splice variant, although retention motifs within GluN1-1a may help act
as a preliminary sorting mechanism.
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Figure IV.4: The “B” GluN1 variants containing Exon 5, an ~25 amino acid inclusion in
the N-terminal domain, were also evaluated due to the known role of N-terminal domain
alignment in receptor complex assembly. Statistical comparison of A and B variant
GluN1+/GluN1- ratios yielded no significant results suggesting the presence of Exon 5
does not affect triheteromeric NMDA receptor assembly. (Two-way ANOVA; interaction p
> 0.05, F2,60 = 3.022; A/B subtype p > 0.05, F1,60 = 0.422; splice variant p < 0.0001,
F2,60 = 15.18)
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Figure IV.5: Linear regression analysis of Acceptor/Donor expression and Net BRET
signal reveals no significant correlation, indicating that the signal observed is reflective
of a specific interaction. Furthermore, expression of 2B-Rluc with soluble YFP elicits
minimal BRET signal (data not shown), lending further support for the specificity of the
BRET signal.

IV.4 Discussion
As revealed by the BRET data, it appears that splice variants of GluN1
that possess alternative C-termini do not significantly contribute to triheteromeric
GluN1/GluN2A/GluN2B assembly within the ER. While reports have shown that
significant ER retention motifs within the C-termini of GluN1 splice variants can
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greatly impact surface delivery of NMDA receptors, the presence of the C1
cassette appears to largely dictate retention of NMDARs as total C-terminal
truncation does not alter receptor membrane expression (Ehlers et al., 1998;
Scott et al., 2001; Meddows et al., 2001). Indeed, our data as well as studies
showing mutation of select residues within the C1 cassette or masking of C1
retention motifs by additional cassettes effectively relieve ER sequestration
(Ehlers et al., 1998; Riou et al., 2012). Taken together, this data argues that the
C-terminal alternative splicing of GluN1 may largely be a mechanism to dictate
post-assembly targeting of fully complemented receptors, and does not
significantly participate in GluN1/GluN2 co-assembly.
Further work has shown that N-terminal residues may instead be
essential regulators of GluN1/GluN2 subunit association. While experiments
have shown that N-terminal regions of GluN1 and GluN2 contain additional ER
retention motifs, observations that their progressive deletion correlates with both
blunted surface delivery and heightened presence of GluN1 homodimers argues
that their presence is essential in the recognition and resulting co-assembly of
GluN1 and GluN2 (Meddows et al., 2001; Qiu et al., 2009). Strangely, however,
we did not observe any differences in net BRET between the “A” and “B” variants
suggesting that such N-terminal recognition between GluN1 and GluN2 occurs
regardless of the GluN2 subtype or does not involve the residues coded by Exon
5.
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Thus, while discrete regions within GluN1 appear to be essential in both
the assembly of complete NMDA receptor complexes as well as the exit of these
receptor complexes from the endoplasmic reticulum, they do not appear to
participate in the directed formation of triheteromeric GluN1/GluN2A/GluN2B
receptors. Given the role of GluN1 and GluN2 C-termini in facilitating interactions
with synaptic scaffolding proteins such as neuronal filaments and α-actinin, it
seems much more likely that triheteromeric assembly is a stochastic process,
and that post-assembly interactions in the secretory pathway govern synaptic
enrichment of triheteromeric NMDARs (Wyszynski et al., 1997; Ehlers et al.,
1998; Scott et al., 2001; Scott, Blanpied, & Ehlers, 2003). It remains unknown,
however, if the presence of subtype-specific C-termini of GluN2 subunits can
either regulate triheteromeric assembly or influence post-assembly trafficking
distinct from diheteromeric NMDARs, and represents an interesting future
direction for understanding the process of triheteromeric NMDA receptor
expression.
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Chapter V: Discussion
V.1 Summary of Findings
In Section I, the essential role of the N-methyl-D-aspartate receptor in
neurotransmission was detailed with special emphasis on outlining the
dichotomous function of NMDAR-mediated activity in synaptic signaling.
Specifically, the relationship between intrinsic magnesium sensitivity, high
calcium permeability, and high propensity for calcium-dependent inter-molecular
signaling of NMDARs were discussed to impress the importance of this receptor
in a number of synaptic processes including long term potentiation, understood to
be the molecular basis for learning and memory. Such pains were taken in order
to demonstrate how the preferential activity of alcohol, its predilection for NMDAR
antagonism in particular, at this receptor can elicit profound behavioral
manifestations such as acute intoxication, and that with continued exposure
compel the induction of pathological behaviors that drive further alcohol abuse.
While much is now known both of the role of NMDARs in synaptic
plasticity as well as the actions of ethanol on NMDA receptor function, gaps in
knowledge nevertheless remain. One such glaring example is a persistent
disregard for NMDA receptor subtype in teasing the actions of alcohol both on
intrinsic

receptor

function

and

on

NMDAR-dependent

inter-molecular

interactions. Thematically, then, the research I have conducted and presented
here has sought to further parse the mechanisms of ethanol action on NMDA
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receptors by discriminating them according to subtype, GluN2A- and GluN2Bcontaining types in particular.
Though the overarching hypothesis of Section II sought to determine what,
if any, role extracellular linker domains had in dictating intrinsic sensitivity of
NMDARs to ethanol, a corollary posited that manipulation of these domains could
reveal essential differences in ethanol sensitivity between GluN2A- and GluN2Bsubtypes. Indeed, while the data presented show that linker domains are not
major determinants of receptor sensitivity to ethanol, the experimental methods
employed did reveal essential differences in gating between the GluN2 subtypes
that do affect the innate sensitivity of the receptor to alcohol. As these results are
among the first to describe this phenomenon, their significance remains to be
determined.
Section III similarly sought to parse GluN2A- and GluN2B-intrinsic ethanol
actions by seeking to reveal whether the subunit-specific post-translational
modifications of GluN2B described in Sections I.9-10 and III.1 could account for
the differential potencies of ethanol between these subtypes. As previously
discussed, the dephosphorylation of select tyrosine residues on the distal Cterminus of GluN2B is correlated with inhibition of NMDAR-mediated current by
alcohol in neurons, and these sites are not found in homologous positions in
GluN2A. Mutation of these residues to a non-phosphorylatable phenylalanine
showed that these sites to do not significantly affect either basic receptor function
or alcohol sensitivity. Indeed, this data corroborates results observed in Section
108

II; namely, that essential differences in channel gating between GluN2A- and
GluN2B-containing NMDARs dictate their differential sensitivities to ethanol, not
extraneous, subunit-specific sites of action.
Finally, Section IV.1 detailed the accumulating evidence suggesting that
not only do NMDA receptors exhibit myriad different GluN2 subunit types, but as
well that different GluN2 subunits heterogeneously assemble within individual
receptors, adding further complexity to an already diverse receptor pool. Many
significant questions remain regarding these novel triheteromeric receptors,
however, we wished to determine whether the obligate GluN1 subunit, and its
eight potential splice variants, could bias the formation of diheteromeric or
triheteromeric GluN1/GluN2A/GluN2B receptor types. From the data presented,
we conclude that such a case is unlikely, and that diheteromer/triheteromer
receptor sorting occurs at a level beyond initial ER assembly.
V.2 Future Directions
While linker domains do not appear to participate significantly in defining
the intrinsic sensitivity of NMDA receptors to ethanol, results observed in Section
II nevertheless reveal new insights into the inherent function of and alcohol action
on different NMDAR subtypes. That intrinsic differences in channel gating may
partially define the idiosyncratic sensitivities to ethanol observed between GluN2
subtypes is especially interesting when considering the fundamentally different
roles of NMDA receptor types in eliciting plastic phenomena such as long term
potentiation and depression. It would be especially interesting to probe whether
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such innate differences in alcohol sensitivity between the subtypes not only is a
key determinant in driving the GluN2B-centric metaplastic mechanisms detailed
in Sections I.9-10 and III that occur with chronic alcohol exposure, but as well
these innate differences participate, if at all, in propagating the hedonic valence
of alcohol intoxication. With the development of CRISPR-Cas9 technology,
engineering knock-in mice that can display altered sensitivities of specific GluN2
subunits could be an invaluable resource to probe these very questions.
In a similar vein, it is unclear as to whether the metaplastic events detailed
in Section III.1 are in any way related to the acute inhibition of NMDAR-mediated
current by ethanol. Specifically, whether or not the effect of alcohol on NMDAR
current, modest as it is, alters receptor signaling in such a way as to recruit
GluN2B/STEP interactions, or if instead induction of STEP is an unrelated,
upstream process. Again, creating a viable knock-in mouse expressing an
alcohol insensitive mutant GluN2B subunit would allow for this phenomenon to
be tested. Recent efforts by our laboratory to do this have so far been
unsuccessful.
In Section IV the intriguing question was posed as to the functional
significance of novel triheteromeric GluN1/GluN2A/GluN2B NMDA receptors in
the pathogenesis of alcohol use disorders. Since relatively little is known about
the function and expression of these receptor populations, reflected by a dearth
of studies specifically addressing them in the literature, they represent fertile
ground for research. While the expression of these receptors appears dependent
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on a process distinct from GluN1-directed assembly, more elementary questions
abound. Indeed, it remains unknown as to whether this receptor population is
predominantly synaptic or extrasynaptic, much less whether chronic alcohol
exposure alters their presence on the membrane.
V.3 Final Thoughts
The paramount reason for studying addiction is presumably in the noble
pursuit of a cure. However, the ever-present lack of a “magic bullet” for alcohol
use disorders even in the face of the decades of research outlined in Section I
highlights the monumental difficulty in achieving such a goal. At its root, the
problem is likely the sum of two factors, one being a research paradigm that has
placed significant emphasis on small molecule treatments, thereby reducing
complex cognitive disorders down to single molecules that target single
receptors. The experimenters are not entirely to blame, as much of addiction
research funding stems from publically supported institutions that expect extrinsic
dividends for their support. The other, related factor stymying addiction treatment
has been the rather slow development of effective non-invasive tools for treating
cognitive disorders with minimal off-target effects. Indeed, such tools have only
very recently come to the fore, in the form of transcranial magnetic stimulation
(TMS) in its many iterations.
As to the first point, study of organic disorders often begins at the genetic
or molecular level since many diseases are characterized by high-penetrance
genetic mutations including Fragile X Syndrome, or diseases of acquired
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receptor/protein dysfunction as observed with neurofibrillary tangles and
aggregated amyloid-β protein that are the hallmarks of Alzheimer’s Disease.
While most clinicians agree that addiction is an organic disorder, and the NMDAmediated metaplastic adaptations discussed in Section III.1 reflect this, the
pathogenesis of the disease appears to begin at a much higher functional level.
Indeed, divining the root cause of why people abuse ethanol in the first place
highlights the intrinsically higher-order cognitive nature of addiction. To be sure,
profound molecular adaptations are known to occur that proffer the addicted
state, however targeting the symptoms rarely, if ever, cures the underlying
disease. Thus, a tenable and lasting treatment for alcohol addiction likely lies in
the implementation of novel therapies such as TMS whose therapeutic
mechanisms seek primarily to re-engage and potentiate the activity of atrophied
regions of executive function such as the dorso-lateral prefrontal cortex and as a
result re-instill higher-order cognitive control on the patient’s over-represented
limbic drives. Collaborative pilot studies between the NIAAA and the University of
Palermo have in fact demonstrated the power of this technique in treating
cocaine addiction and likely portend a substantial increase in its clinical use
(Terraneo et al., 2016).
This is not to say that molecular pharmacological research has nothing of
value to offer; quite the contrary. As outlined in Section I.1, the value of addiction
research is intrinsically two-fold. Explicitly, it incrementally leads experimenters
towards a cure or solution for a costly, both emotionally and financially, problem.
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As well, though, to echo the point made in Section I.1, it implicitly informs
ourselves about ourselves. As the architects of computers, human beings have
the luxury of stacks upon stacks of circuit diagrams, manuals, and procedures
that display in exquisite detail the mechanics and coding that make up electronic
computing, from the higher-order graphical user interface down to the level of
elementary voltage-dependent floating gates that comprise flash memory. By
comparison, our collective understanding of the human brain is woefully
incomplete, and is perhaps best exemplified by the persistent, and false, belief
on the part of the general public that at any given time a person uses merely 10%
of their brain – something one would do well not to attempt! While our
understanding of the machinations of the mind pale in comparison, our approach
to problem solving when an error is encountered follows a similar procedure,
whether it be an organic or electronic “brain.”
One first identifies at what level the error appears to originate. Alcohol
intoxication is characterized by cognitive depression, leading to hypotheses that
it inhibited excitatory neurotransmission that were ultimately confirmed.
Researchers then focused their attention to the next level down, interrogating
what molecular substrates elicited such depression of excitation. With the
concerted efforts of an entire field, such a line of questioning not only parsed
glutamatergic neurotransmission into three distinct receptor classes, identifying
the NMDA receptor as a critical site of alcohol action, but also highlighted the
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central importance of this receptor in the manifestation of learning and memory –
a biological equivalent to the floating gates of flash memory.
By this analogy, we begin appreciate the latent value of molecular
biological research, and by understanding the low-level intra- and inter-molecular
interactions that percolate up into higher order cognitive processes, a view to
treatment becomes clearer. These islands of insight discovered a fortiori in the
pursuit of elevating the health of humanity legitimize and reinforce the argument
that research is a universally sound investment – quaerendo invenietis.
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